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ABSTRACT 
The purpose of this study was two-fold, 1) to extract and quantify vitamin E components 
from rice bran using microwave extraction, to determine the antioxidant activity of the rice bran 
oil, and the effect of solvent and temperature on vitamin E components and oil yield, and 2) to 
entrap alpha-tocopherol into polymeric nanoparticles, to characterize the nanoparticles in terms 
of morphology, size and size distribution, zeta potential, entrapment efficiency, and amount of 
residual PVA associated with the nanoparticles, as well as to study the release of alpha-
tocopherol from PLGA nanoparticles.  
Microwave-assisted extraction was an efficient method for the extraction of oil and 
vitamin E components from rice bran. Hexane was a better solvent for rice bran oil extraction as 
compared to isopropanol at 40ºC. At higher temperature, isopropanol was a better solvent for oil 
extraction. Hexane extracted large amount of α-tocotrienol at 120ºC while the increase in 
temperature for isopropanol was more beneficial for the extraction of γ-tocopherol. No 
significant differences in the oil yield, total vitamin E, and antioxidant activity of rice bran oil 
was noticed between the conventional solvent and microwave-assisted extractions, at 40ºC.  
For the second part of the study, emulsion evaporation method was used to synthesize 
spherical PLGA(αT) nanoparticles with SDS and PVA as surfactants. For SDS nanoparticles, the 
size of the nanoparticles decreased significantly with the entrapment of α-tocopherol in the 
PLGA matrix, while the size of PVA nanoparticles remained unchanged. The PDI after synthesis 
was under 0.100 for PVA nanoparticles and around 0.150 for SDS nanoparticles. Zeta potential 
was negative for all PVA nanoparticles. The entrapment efficiency of α-tocopherol in the 
polymeric matrix was approximately 89% and 95% for nanoparticles with 8% and 16% α-
tocopherol theoretical loading. The residual PVA associated to the nanoparticles after 
purification was approximately 6% (w/w relative to the nanoparticles). The release profile 
showed an initial burst followed by a slower release of the α-tocopherol entrapped inside the 
PLGA matrix. The release for nanoparticles with 8% α-tocopherol theoretical loading (86% 
released/first hour) was faster than the release for the nanoparticles with 16% α-tocopherol 
theoretical loading (34% released/first hour).  
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 CHAPTER 1. INTRODUCTION 
 
Many studies demonstrate the role of vitamin E vitamers in prevention of some chronic, 
age-related diseases such as cardiovascular diseases, atherosclerosis, cancer, arthritis, 
Alzheimer’s, and Parkinson’s (Brigelius-Flohe and Traber, 1999; Shui and Leong, 2005; Lloyd 
et al., 2000; Bramley et al., 2000, Wayner et al., 1987; Wang et al., 1996). These studies 
correlated the vitamin E activity with its function as a chain-breaking antioxidant that stops the 
free radical reactions (Brigelius-Flohe and Traber, 1999). The role of vitamers and, especially of 
α-tocopherol as an antioxidant is based on the high stability of α-tocopheroxyl radical, which is 
formed by loosing the phenolic hydrogen. The newly formed radical can bind another radical 
resulting in a non-radical product, or it can reconvert to α-tocopherol. Alpha-tocopheroxyl 
radical is quite stable because of the unpaired electron of the atom of oxygen which is 
delocalized in the aromatic ring (Bramley et al., 2000). The analytical methods used for detection 
of alpha-tocopherol are: spectrophotometry, fluorometry, electrochemistry, and light-scattering 
(Bramley et al., 2000).  
Sources of vitamin E are wheat-germ oil, sunflower seed, almond, cereals, and others. 
Rice bran represents one of the rich sources of vitamin E components. Rice bran oil contains 
about 0.1-0.14% vitamin E components, concentrations that can vary substantially according to 
the origin of the rice bran (Diack and Saska, 1994; Lloyd et al., 2000; Hu et al., 1996). Several 
methods have been developed to extract vitamin E components from rice bran, namely 
supercritical fluid extraction, solvent extraction, and Soxhlet extraction. Microwave extraction is 
a newly developed extraction method which overcomes some drawbacks associated with the 
conventional extraction methods. Microwave-assisted extraction can be completed in minutes, 
polar or non-polar solvents can be used, a precise software-based control of all parameters of the 
extraction can be achieved, a higher analyte recovery can be obtained compared to other 
methods, and low amounts of solvent are needed (Ondruschka and Asghari, 2006; Eskilsson and 
Bjorklund, 2000).  
Once extracted and purified, vitamin E vitamers can be delivered in several forms, free 
form, as a derivative (i.e. tocopheryl acetate), as an emulsion, or in nanoencapsulated form. 
Delivery of vitamins entrapped in polymeric nanoparticles has definite advantages over the 
delivery of non-entrapped vitamins. The release rate of the vitamins can be controlled and 
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consequently the dose frequency can be reduced. Furthermore, the bioactivity and stability of the 
active substance entrapped in the nanoparticle is protected (Lamprecht et al., 2001; Niwa et al., 
1993; Uhrich et al., 1999; Mu and Feng, 2003). Alpha-tocopherol is sensitive mostly to oxygen, 
light, and temperature, and therefore the entrapment of alpha-tocopherol in a polymeric matrix 
may protect it from these environmental factors. Experimental results show that the half-life of 
compounds incorporated in nanoparticles is much longer than the half-life of non-encapsulated 
drugs. Another advantage of entrapment is that drugs are delivered more slowly and at a more 
constant rate, avoiding the high hepatotoxicity of the drug (Mainardes et al., 2005; Redhead et 
al., 2001). Also, drug bioavailability increases when the drugs are entrapped in nanoparticles 
(Lee et al., 2002), factor which is critical for lipophylic components such as vitamin E.  
The goal of the present research was to extract vitamin E components from rice bran and 
to entrap the most biological active vitamin E vitamer, alpha-tocopherol, into a PLGA matrix in 
order to obtain small size nanoparticles. The thesis is divided into two main sections. Section one 
focuses on microwave-assisted and conventional solvent extraction of vitamin E components 
from rice bran oil; quantification of these components as well as determination of antioxidant 
activity of rice bran oil constitutes one of the main objectives of this research. The second 
section is oriented toward the entrapment of the most active vitamin E vitamers (alpha-
tocopherol) into polymeric nanoparticles; characterization of the synthesized nanoparticles in 
terms of morphology, size and size distribution, zeta potential, entrapment efficiency, as well as 
the study of the sustained release of alpha-tocopherol from PLGA nanoparticles also make the 
objectives of this section. 
The objectives of this research were:  
Objective 1. Extraction of vitamin E components from rice bran using microwave extraction 
a) Extraction of rice bran oil from rice bran by microwave-assisted method 
b) Quantification of tocopherols and tocotrienols in the extracted oil  
c) Determination of antioxidant activity of the rice bran oil 
d) Study of the effect of solvent and temperature on alpha-tocopherol degradation. 
 
Objective 2.  Entrapment and release of   alpha-tocopherol from polymeric nanoparticles 
a) Synthesis of poly (D,L-lactide-co-glycolide) nanoparticles with entrapped α-
tocopherol by emulsion evaporation method, with PVA and SDS as surfactants 
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b) Characterization of PLGA(αT) nanoparticles in terms of morphology (TEM), 
size,  size distribution, and zeta potential (DLS), and entrapment efficiency 
(HPLC) 
c) Study of the α-tocopherol release from PLGA(αT) nanoparticles. 
1.1. Extraction of Vitamin E Components 
 Extraction of rice bran oil by microwave assisted extraction, as well as determination of 
its antioxidant activity and quantification of vitamin E components is included in Chapter 2. 
Many studies reported the use of microwave-assisted method for the extraction of antioxidants 
but only a few reported the use of microwave energy for the extraction of rice bran components 
(Duvernay et al., 2005). In this study, conventional solvent and microwave-assisted extractions 
were used as methods for the extraction of rice bran oil and rice bran components. The 
extractions temperatures were 40, 60, 80, 100, and 120ºC based on the similar conditions studied 
by Duvernay et al. (2005). For conventional solvent extraction 40ºC was chosen as the extraction 
temperature in order to compare the results with those obtained by microwave-assisted 
extraction. A polar solvent, isopropanol, and a non-polar solvent, hexane, were used for the 
extraction of rice bran oil. In this study, four vitamin E components, α- and γ- tocopherol and α- 
and γ- tocotrienol in the rice bran oil were quantified by normal-phase HPLC. The antioxidant 
activity of rice bran oil was tested by using DPPH radical scavenging capability. The α-
tocopherol degradation study was performed in the same conditions as microwave-assisted 
extraction of rice bran oil. 
1.2. Alpha-tocopherol Encapsulation and Release from PLGA Nanoparticles 
The study on alpha-tocopherol encapsulation and release from PLGA nanoparticles is 
presented in Chapter 3. Emulsion-solvent evaporation was chosen as a method for the 
entrapment of alpha-tocopherol in the PLGA matrix. Many studies reported the use of emulsion 
evaporation method for nanoparticle preparation and entrapment of various drugs (Mainardes et 
al., 2005; Li et al., 2001; Mu and Feng, 2002; Muller,1990; Cascone et al., 2002; Birnbaum and 
Brannon-Peppas, 2003, Astete and Sabliov, 2005). The parameters which affect the size of the 
nanoparticles, and implicitly the release of the active component from the polymeric matrix are 
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presented in this section of the thesis. The parameters for synthesis of PLGA nanoparticles with 
entrapped α-tocopherol were selected based on the literature. Dichloromethane and ethyl acetate, 
in which both the polymer and the drug are soluble, were used as solvents for the preparation of 
the organic phase. The aqueous to organic ratio was chosen as 10:1, and Poly(DL-Lactide-co-
Glycolide) (PLGA) was selected because of its bio-compatibility properties. PLGA 50:50 with a 
molecular weight of 45,000-75,000 was used as the matrix for drug entrapment. Another 
advantage of PLGA, besides the fact that it is degradable to non-toxic compounds, is that by 
changing the ratio of the monomers in the co-polymer the release rate of the drug can be 
controlled (Yoo, 2000). Hydrophilic and hydrophobic drugs can be entrapped by emulsion 
evaporation method (Mainardes et al., 2005, Redhead et al., 2001) with a higher entrapment 
efficiency for hydrophobic drugs than for hydrophilic components (Birnbaum and Brannon-
Peppas, 2003). Alpha-tocopherol, a hydrophobic drug, was entrapped into the PLGA matrix 
using the single emulsion evaporation technique. A solution of 0.3% PVA (30,000-70,000 Da) 
and a solution of 2 mg/ml SDS was used as a surfactant in the aqueous phase. Sonication time 
was selected at 2 minutes in pulse mode with 38% amplitude at 750 W. Trehalose was added as a 
cryoprotectant to the particles before lyophilization. 
The morphology of the nanoparticles was studied by Transmission Electron Microscopy 
(TEM). The size, size distribution, and zeta potential were measured by dynamic light scattering 
(DLS). The entrapment efficiency and release of alpha-tocopherol were studied by RP-HPLC.  
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CHAPTER 2. DETERMINATION OF ANTIOXIDANT COMPONENTS 
IN RICE BRAN OIL EXTRACTED BY MICROWAVE-ASSISTED 
METHOD 
2.1. Introduction 
2.1.1. Rice Composition 
Rice is a good source of calories provided by its high content of starch and high 
nutritional quality proteins; it is hypoallergenic and easily digested (Mazza, 1998). Besides the 
nutritional quality of rice, its antioxidant properties are also exceptional. The rice bran oil 
antioxidants are very efficient in reducing low density lipoprotein and total serum cholesterol 
(Hu et al., 1996; Mazza, 1998; Sugano and Tsuji, 1997; Kim, 2005; Rukmini and Raghuram, 
1991). Almost all the oil of the rice grain is located in the bran and germ (Kim et al., 1999). 
Clean rice bran contains 20-22% oil by weight (Mazza, 1998) but dilution of the rice bran 
during the milling process with other components such as hull and starch diminish the oil content 
to 15-20% (Shen et al., 1996; Mazza, 1998). Approximately 95-98% of the oil is extractable 
(Amarasinche and Gangodavilage, 2004). Rice bran oil contains a saponifiable fraction formed 
from saturated and unsaturated fatty acids and an unsaponifiable fraction containing tocopherols, 
γ-oryzanol, and squalene (Rukmini and Raghuram, 1991). The amount of rice components varies 
as a function of rice type, climatic conditions, storage conditions, rice bran stabilization, and 
processing methods (Amarasinche and Gangodavilage, 2004; Mazza, 1998), but it typically 
contains 88-89% neutral lipids, 3-4% waxes, 2-4% free fatty acids and approximately 4% 
unsaponifiables (Kim et al., 1999). Rice bran oil contains about 0.1-0.14% vitamin E 
components and 0.9-2.9% oryzanol; the concentrations can vary substantially according to the 
origin of the rice bran (Diack and Saska, 1994; Lloyd et al., 2000; Hu et al., 1996).  
Vitamin E is a generic term for a group of four tocopherols (α-,β-,γ- and δ-) and four 
tocotrienols (α-,β-,γ- and δ-), of which α-tocopherol has the highest biological activity (Shin and 
Godber, 1993; Duvernay et al., 2005; Brigelius-Flohe and Traber, 1999; Bramley et al., 2000).  
These components are yellow, viscous liquids which are insoluble in water, but are readily 
soluble in organic solvents. A number of factors such as: oxygen, light, heat, alkali, trace 
minerals, and hydroperoxides can cause decomposition of vitamin E vitamers (Bramley, 2000). 
All components of vitamin E have an amphyphilic structure with a hydrophilic part (chromanol 
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ring) and a hydrophobic part (isoprenoid side chain) as shown in Figure 2.1. A number of studies 
showed that vitamin E functions as a chain-breaking antioxidant that prevents the propagation of 
free radical reactions (Brigelius-Flohe and Traber, 1999; Becker et al., 2004; Huang et al., 2002).  
Because of its radical scavenging antioxidant properties, vitamin E inhibits lipid peroxidation in 
vitro and in vivo (Niki and Noguchi, 2004; Kim et al., 1999).  
The other antioxidant found in rice bran oil, oryzanol is a mixture of esters of ferulic acid 
with sterols and triterpene alcohols and has similar antioxidant properties with vitamin E 
vitamers (Shin et al., 1997). Among the oryzanol components found in the rice bran cycloartenol, 
β-sitosterol, 24-methylene-cycloartanol, cyclobranol (cycloartenol), and campesterol (4-
desmethysterols) are most prevalent (Lloyd et al., 2000). The oryzanol concentration in crude 
rice bran oil can reach 2% (v/v) (Lloyd et al., 2000). 
2.1.2. Antioxidant Activity of Rice Bran Oil Components Found in Rice Bran Oil 
It is believed that the implications of vitamin E vitamers and oryzanol in the prevention 
of some chronic age-related diseases such as cardiovascular diseases, atherosclerosis, cancer, 
arthritis, Alzheimer’s, Parkinson’s are related to their antioxidant function (Brigelius-Flohe and 
Traber, 1999; Shui and Leong, 2005; Lloyd et al., 2000; Bramley et al., 2000, Wayner et al., 
1987; Wang et al., 1996).  
Antioxidants can be classified as a function of their lipid or water solubility, as a function 
of their composition (proteins or small molecules) (Papas, 1996), or based on their function in 
plasma. In plasma, primary antioxidants can bind metal ions and as such they can reduce the 
initiation rate of lipid peroxidation; secondary antioxidants (i.e. α-tocopherol) act by reducing the 
chain propagation and amplification of lipid peroxidation (Ghiselli, 1995). 
There are large numbers of oxidant capacity assays that use chemical 
chromogenic/fluorescent redox reactions to test antioxidant properties of different chemical 
components. Other methods are based on the properties of the biological systems; for example, 
the integrity of the cellular membrane is correlated with LDH (lactate dehydrogenase) leakage 
(Yu, 1999). Among the oxidative species used in vitro for testing the scavenging capacity of 
different antioxidants,  hydrogen peroxide, peroxynitrite, 2,2’-azino-bis(3-ethylbenzthiazoline-6-
sulfonic acid)  or ABTS, and 1,1- diphenyl-2-picrylhydrazyl (DPPH) are most commonly used 
(Miller, 2001; Hoelzl et al., 2005; Miller et al., 1993). DPPH method was reported in the 
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literature as a suitable means to evaluate the antioxidant activity of different vegetable oils and it 
was selected as the method of choice in the present study to measure antioxidant activity of the 
rice bran oil (Espin et al., 2000; Parry et al., 2005; Oufnac et al., in press).  
 
 
Figure 2.1. Chemical structure of vitamin E components (A-tocopherols, B-tocotrienols) 
(Shin and Godber, 1994) 
2.1.3. Extraction Methods Used for Isolation of Rice Bran Oil Antioxidants 
Various techniques used for extraction, isolation and purification of antioxidants from 
rice bran oil have been described in the literature (Shin, 1993, Xu, 1999, Rogers, 1993, Shen, 
1997, Shin, 1994). It is commonly accepted that the avoidance of the oxidation of the compounds 
(Diack and Saska, 1994; Shin, 1997) is an important step during the process. For example, if rice 
bran is held at elevated temperature after extraction, the endogenous antioxidants can be 
degraded by temperature, especially during long term storage. Therefore, it is recommended that 
following extraction to work and to store the samples at the lowest possible temperature (Shin, 
1997).  
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Rice bran is rapidly oxidized resulting in free fatty acids which affect the quality of rice 
bran oil (Amarasinche and Gangodavilage, 2004; Mazza, 1998).  After milling, free fatty acids 
are formed at an initial rate of 5-7% by weight of oil per day as a result of lipase activity. 
Therefore, the stabilization of rice bran as soon as possible after milling is an important step in 
analyzing of rice bran oil components. Stabilization of rice bran can be achieved by controlling 
the lipase activity (Mazza, 1998). A widely used technique for bran stabilization is drying and 
steaming of bran, but other methods such as ohmic heating, refrigeration and chemical 
stabilization can also be used (Amarasinche and Gangodavilage, 2004; Lakkakula et al., 2004). 
Shin et al. (1997) studied the effect of storage conditions on retention of vitamin E vitamers and 
oryzanol. Raw rice bran was stored at ambient temperature and the variation of its components 
was monitored during one year period. In only 35 days the total vitamin E lost was 44% and the 
order of losses of vitamin E components and oryzanol was: α-T ≥ α-T3 > γ-T3 > γ-T ≥ δ-T3 ≥ β-
T ≥ δ-T > oryzanol. Based on this order, α-tocopherol and α-tocotrienol proved to be the less 
stable among all vitamin E components during the first 35 days period. Mazza et al (2002) 
proved that tocopherols and tocotrienols were oxidized very slowly by atmospheric oxygen and 
in dark conditions. In a medium without oxygen tocopherols and tocotrienols could be heated up 
to 200ºC without showing any degradation. 
Organic solvents, water, and supercritical carbon dioxide have been used for the 
extraction of rice bran oil (Amarasinche and Gangodavilage, 2004; Hu et al., 1996; Proctor and 
Bowen, 1996; Kuk and Dowd, 1998). The most common solvent used for extraction of edible 
oils is hexane (Bera, 2006; Mazza, 1998); hexane is the solvent of choice used to extract rice 
bran oil for commercial purposes (Hu, 1996). Isopropanol can be used as an alternative solvent 
when the hexane flammability is of concern (Proctor and Bowen, 1996). Bera et al. (2006) 
studied the effect of solvents on the extraction of some edible oils (flax seed oil and bahera oil) 
from seeds and found that solubility of the oils in isopropanol increased with temperature; at 
30ºC the solubility of oils in isopropanol was 67% (w/w) and the two phases became miscible at 
50ºC. For hexane, the oils and the solvent were miscible even at room temperature. The 
conclusion was that when polar solvents were used, because of the oil solubility change with 
temperature, the extraction yield was more significantly affected by temperature as compared to 
when non polar solvents were used.  
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The nature of the solvent is very important in extraction; polar short-chain alcohols seem 
to be a promising alternative to non-polar solvents for extraction of oil and antioxidants from rice 
bran (Hu et al., 1996; Proctor and Bowen, 1996). Alcohols extract more unsaponifiable 
components and phosphatides, but are poor solvents for triglycerides (Proctor and Bowen, 1996). 
Previous studies were reported on the solvent extraction of rice bran oil by using isopropanol to 
extract rice bran oil enriched in vitamins B and by using ethanol to obtain rice bran oil enriched 
in tocopherols and vitamins B (Hu et al., 1996). Hu et al. (1996) mentioned the use of 
isopropanol and hexane in the extraction of rice bran oil for the recovery of vitamin E and 
oryzanol components. Their studies demonstrated that the amount of crude oil, vitamin E, and 
oryzanol components increased with increasing the solvent-to-bran ratio from 2:1 to 3:1 and by 
rising the temperature from 40ºC to 60ºC. A study on the effect of the two solvents on the 
amount of oil, vitamin E and oryzanol showed that isopropanol extracted more vitamin E, less oil 
amount, and the same quantity of oryzanol as compared with hexane (Hu, 1996).  
Proctor and Bowen (1996) studied the effect of hexane and isopropanol on the extraction 
of rice bran oil at room temperature. Oil yield extracted with hexane and isopropanol from 2 g 
rice bran was similar for both solvents and it was around 15% (Proctor and Bowen, 1996). 
Amarasinche and Gangodavilage (2004) studied the solvent extraction of rice bran oil using 
hexane for a number of rice bran varieties available in Sri Lanka. They found that for all types of 
bran, parboiling bran oil yield was higher compared with raw bran. The oxidative stability of rice 
bran oil under heat induced oxidation at 64ºC for 32 days was also studied by Proctor and Bowen 
(1996). The studies on oxidative stability of rice bran oil extracted with isopropanol and hexane 
showed that the oil extracted with isopropanol was more stable compared with the oil extracted 
with hexane. It was assumed that isopropanol extracted antioxidants which were not present in 
the oil extracted with hexane and those antioxidants protected the oil against oxidation. Since the 
level of phospholipids was the same in both type of oils, the difference in the antioxidant 
stability was attributed to tocopherols assumed to be found in higher concentration in the oil 
extracted with isopropanol than in the oil extracted with hexane (Proctor and Bowen, 1996). 
Many studies were published in the literature related to the effect of various solvents on 
the extraction of rice bran oil using traditional heating methods (Hu et al., 1996; Proctor and 
Bowen, 1996). Microwave assisted solvent extraction is a relatively new extraction method that 
can be alternatively used for extraction of oils. The system is specially designed to operate at 
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elevated temperatures and pressures monitored by a fiber optic temperature probe and a pressure 
control side arm, respectively (Carro et al, 2000).  The number of parameters needed for 
optimization of microwave extraction is lower and easier to set up as compared with supercritical 
fluid extraction. The disadvantages of supercritical fluid extraction and accelerated solvent 
extraction are higher cost of the equipments and the blockages in the systems as a result of the 
presence of water in the sample (Camel, 2000). The parameters usually studied for the 
optimization of microwave-assisted extraction are pressure or temperature, extraction time, 
microwave power, solvent composition, solvent volume, and matrix characteristic including 
water content (Camel, 2000; Eskilsson and Bjorklund, 2000; Bum, 2000). The selection of the 
solvent is an important step for obtaining optimal extraction results.  The best solvent for 
microwave-assisted extraction should present a high selectivity to the analyte, good solvent-
matrix interaction, and high microwave-absorbing properties (Eskilsson and Bjorklund, 2000). 
The highest dielectric constant of the solvent provides high thermal energy and consequently 
rapid heating. An example of solvent used for microwave-assisted extraction with low dielectric 
constant which does not absorb microwave energy, and therefore it does not heat is hexane 
(Eskilsson and Bjorklund, 2000). A low dielectric constant solvent such as hexane is used as a 
way to prevent the degradation of thermolabile components (Camel, 2000; Ondruschka and 
Asghari, 2006); in this case only the sample matrix is heated and the solute is released into the 
cold solvent.  
In microwave-assisted extraction, the analyte migrates out from the matrix through the 
solvent while in classical solvent extractions the solvent diffuses into the sample matrix and 
solubilizes the analyte (Camel, 2000). The benefits of the microwave-assisted solvent extraction 
consist in that it can be completed in minutes, polar or non-polar solvents can be used, a precise 
software-based control of all parameters of the extraction can be achieved, a higher analyte 
recovery can be obtained compared to other methods, and low amounts of solvent are needed. 
The microwave-assisted method has further advantages including the fact that it is reproducible, 
the solvent can be heated over its boiling point resulting in the increase of extraction efficiency 
and speed, and simultaneous analysis of samples can be performed (Ondruschka and Asghari, 
2006; Eskilsson and Bjorklund, 2000).  
Microwave-assisted extraction was reported to be useful in extracting persistant organic 
pollutants, pesticides, phenols, metals, polymers, and pharmaceuticals and natural products 
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(Eskilsson and Bjorklund, 2000). Comparable efficiencies and reproducibility relative to 
conventional extraction methods were obtained in all reported studies.  Microwave-assisted 
extraction of tanshinones from the roots of S. miltiorrhiza bunge (Pan et al., 2002) and of 
flavanoids from cultured cells of Saussurea medusa maxim (Gao and Liu, 2005) proved to be the 
most efficient technique as compared to the extraction of these compounds by heat reflux 
extraction, ultrasonic extraction, Soxhlet extraction, and extraction at room temperature (Pan et 
al., 2002). Better extraction efficiency in a short time of tea polyphenols and tea caffeine was 
obtained by microwave-assisted extraction as compared to ultrasonic, heat reflux and extraction 
at room temperature (Pan et al., 2003).  
Duvernay et al. (2005) found that microwave extraction of rice bran oil was comparable 
to solvent extraction and suggested that a ratio solvent-to-bran of 3:1 and high temperatures 
increased the amount of oil and the quantity of antioxidants extracted with isopropanol from rice 
bran by using microwave extraction. A temperature increase from 80 to 110ºC produced an oil 
yield increase of 18% and a total vitamin E increase of 33%.   
2.2. Objectives 
The objectives of this study were: 1. to compare isopropanol and hexane as extraction 
solvents, by both microwave-assisted and conventional solvent methods; 2. to evaluate the oil 
yield and vitamin E yield as a function of extraction temperature; 3. to measure the effect of 
isopropanol and hexane as well as the effect of temperature on the antioxidant activity of the rice 
bran oil extracted; 4. to study the temperature and microwave effect on the degradation of alpha-
tocopherol.  
2.3. Materials and Methods 
2.3.1. Chemicals and Materials 
 The rice bran used in the extraction studies was obtained from Cypress rice provided by 
Rice Research Station (Crowley, LA). HPLC grade methanol, hexane, and ethyl acetate were 
ordered from EMD chemicals (EMD chemicals Inc., Gibbstown, NJ), and 2,2-diphenyl-1-
picrylhydrazyl (DPPH) was acquired from ScienceLab.com (ScienceLab.com, Inc., Houston, 
TX). Alpha-tocopherol, 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox) were 
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purchased from Sigma-Aldrich (St. Louis, MO), isopropanol from Mallinckrodt Chemicals 
(Mallinckrodt Baker, Inc., Phillipsburg, NJ), and acetic acid from Fisher Scientific (Fisher 
Scientific, Springfield, NJ).  
2.3.2. Rice Bran Preparation 
Rice was milled using a Satake pilot scale rice mill (Satake Engineering, Co., Tokyo, 
Japan) located within the Biological and Agriculture Department at Louisiana State University; 
the mill was equipped with two operational units: shelling unit (Model GPS300A, Satake 
Engineering, Co., Tokyo, Japan) and whitening unit (Model VAF10AM, Satake Engineering, 
Co., Tokyo, Japan). After milling, rice bran was kept in the freezer at - 20ºC.  
2.3.3. Microwave Assisted Solvent Extraction 
In order to obtain crude rice bran oil the following procedure was pursued. Samples of 20 
g of rice bran were weighed in each of the three pressure controlled Teflon vessels of the Ethos E 
Microwave Extraction System (Milestone, Inc. Monroe, CT). The Teflon vessels are designed to 
resist elevated pressures produced at temperatures higher than the boiling point of the solvent. As 
solvents for the extraction, a polar solvent (isopropanol) and a non-polar solvent (hexane) were 
used. The ratio of solvent to rice bran was 3:1 w/w. A magnetic stirring rod was added in each 
vessel. The three vessels were sealed and placed in the Microwave Extraction System. The 
Microwave Extraction System was set to operate in two steps. First, temperature gradually 
increased to the set extraction temperature for 5 min, using an energy level of 800 W maximum. 
At the end of the 5 minutes period the extraction temperature was reached. The second step was 
designed to hold the samples for a total period of 15 min at the extraction temperature by using 
an energy level of 500 W maximum. Five extraction temperatures, 40, 60, 80, 100, and 120ºC, 
respectively, were used for microwave assisted extraction. The temperature monitoring of the 
sample inside the vessels was accomplished by a fiber optic probe hooked up to the control 
system. After a ventilation period of 20 min in which the samples were cooled down, the vessels 
were unsealed and each sample was transferred to the filtering device. A vacuum pump (Thomas 
Compressors and Vacuum Pumps, Skokie, IL) was used to filter the solvent and oil mixture 
through a Whatman filter paper Φ=47 mm. After filtration, the mixture of the oil extracted and 
solvent was measured in a graduated cylinder and the volume recovered for each sample was 
recorded. Two milliliters of each sample were placed in a screw cap test tube previously 
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weighed. Two test tubes containing 2 ml mixture were prepared for each sample. These tubes 
were placed in a vacuum centrifuge evaporator (CentriVap Console Labconco, Kansas City, 
Missouri) and they were kept overnight in order to evaporate the solvent. The residual oil for 
each sample was weighed in order to determine the extraction yield. One of the test tubes for 
each sample was used immediately after evaporation to determine the vitamin E vitamers by 
HPLC. The other test tube was flashed with nitrogen in order to keep an inert atmosphere and to 
avoid possible degradation of the oil antioxidants and it was placed in the freezer under dark 
conditions for further antioxidant analysis.    
2.3.4. Conventional Solvent Extraction 
Isopropanol and hexane were the solvents used for the conventional solvent extraction. 
Twenty grams of rice bran was weighed in an Erlenmeyer flask and the volume of solvent 
respective to a 3:1 w/w solvent to bran ratio was added. Each flask was capped with a rubber 
stopper and each sample was shaken well for a better mixing of the bran and solvent. Each 
solvent extraction, with isopropanol and hexane, was done in triplicate. The flasks were placed in 
a 40ºC water bath under shaking for 15 min. The samples were allowed to cool for 20 min and 
were filtered through the filter device previously described. After filtration, the mixture of oil 
and solvent was measured and the volume recovered for each sample was recorded. Two 
milliliters of each sample were placed in a known weight screw cap test tube and two test tubes 
containing 2 ml mixture were prepared for each sample. These tubes were placed in a vacuum 
centrifuge evaporator (CentriVap Console Labconco, Kansas City, Missouri) for the evaporation 
of the solvent overnight. The residual oil for each sample was weighed in order to measure the 
extraction yield. One of the test tubes for each sample was used immediately after evaporation to 
determine the vitamin E components by normal phase HPLC. The other test tube was flashed 
with nitrogen and it was placed in the freezer under dark conditions for further analysis.    
2.3.5. Determination of Vitamin E Components Using HPLC Method 
After evaporation was completed, 2 ml hexane was added to each tube containing rice 
bran oil and each sample was vortexed for 10 sec. The test tubes were placed in a Hermle Labnet 
high capacity centrifuges (Denville Scientific Inc., South Plainfield, NJ) and were centrifuged for 
20 min at 3500 rpm. One milliliter of the supernatant was transferred into a HPLC vial and 25 
µL were injected into the HPLC system. The amount of vitamin E components in the samples 
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was determined by normal phase HPLC. The HPLC system consisted of Waters (Waters, 
Milford, MA) 510 pump, a 715 Ultra WISP injector, and a 470 fluorescence detector. Twenty 
five microliters from each vial were injected into a 25 cm x 4.6 cm diameter of 5 µm Supelcosil 
LC-Si (Supelco, Bellefonte, PA) column. The mobile phase had the following composition: 
98.4% hexane, 0.8% ethyl acetate, and 0.8% acetic acid and the flow rate was 1.5 mL/min. The 
elutant was monitored using the fluorescence detector set at excitation wavelength 290 nm and 
emission wavelength 330 nm. Chromatograms were recorded and processed using Waters 
Millennium chromatography software. Four components of vitamin E, α and γ tocopherol and α 
and γ tocotrienol, respectively were determined and expressed as µg/g fresh rice bran. The total 
vitamin E content was expressed as the sum of all four vitamers.   
2.3.6. The Effect of Microwaves and Heat on Alpha-tocopherol Degradation 
Two samples of a volume of 750 ml alpha-tocopherol at a concentration of 0.10 g/L was 
prepared in isopropanol and hexane. A volume of 1 ml of α-tocopherol in hexane was sampled 
and 25 µl were injected into HPLC system as a control. Samples of 2 milliliters for both solvents 
were placed in two test tubes and were evaporated overnight in a vacuum centrifuge evaporator. 
After evaporation was completed, 2 mL of hexane was added to both test tubes, vortexed for 10 
sec and analyzed by HPLC to assess degradation during evaporation process. 
 To study the effect of microwaves and heat on alpha-tocopherol degradation, 50 
milliliters of sample were placed into the Teflon vessels of the Ethos E Microwave Extraction 
System; the experiments were done in triplicate. The vessels were sealed and placed in the 
Microwave Extraction System which was set to operate in two steps. The first step was the 
increase in temperature gradually using an energy level of a maximum 800 W for 5 minutes; at 
the end of the 5 minutes period the extraction temperature was reached. The second step was 
designed to hold the samples for a total period of 15 min at the extraction temperature by using 
an energy level of a maximum of 500 W. Five different temperatures, 40, 60, 80, 100, and 
120ºC, respectively, were used to assess the effect of microwaves and temperature on the alpha-
tocopherol degradation. Samples were allowed to cool down in the microwave for 20 min and 
two milliliters of each sample were withdrawn and placed in a screw cap test tube. Two 
milliliters of each samples were evaporated overnight in the vacuum centrifuge evaporator and 2 
mL hexane was added to each one and vortexed for 10 sec. One milliliter from each sample was 
 17
transferred to a HPLC vial and 25 µL were injected into the normal phase HPLC previously 
described.  
2.3.7. Antioxidant Activity of Rice Bran Oil 
Determination of antioxidant activity of the rice bran oil was accomplished using DPPH 
radical scavenging method (Oufnac et al., in press). The experiments were performed in 
triplicates. An amount of 0.01 g oil from each sample was dissolved in 500 µL methanol and 
vortexed for 10 sec. Three different volumes of oil dissolved in methanol (40, 80, and 120 µL) 
were added to 2 mL of 25 mg/mL DPPH solution in methanol. The decrease in absorbance was 
monitored at 515 nm by using a UV-Visible Beckman Coulter spectrophotometer (Beckman 
Coulter, Fullerton, CA). The readings were done at time zero, after the oil mixed with the 
methanol was added to DPPH, and after 30 min of incubation at room temperature. The 
inhibition percentage was expressed using the following equation:  
 Inhibition % = (Abst= 0 – Abst= 30 min)/ Abst=0 x 100     [1] 
where Abst= 0 was the absorbance of DPPH at time zero and Abst= 30 min was the absorbance of 
DPPH after 30 min of incubation. The inhibition percentage was plotted against each quantity of 
rice bran oil solution to obtain a regression line.  Trolox (0.5 mM) dissolved in methanol was 
used as a standard to express the inhibition capacity of rice bran oil solution as Trolox 
equivalent. The ratio between the slopes of the regression lines of rice bran oil solution and the 
Trolox solution was expressed as µmol Trolox Equivalent Antioxidant Activity. 
2.3.8. Statistical Analysis  
The means and standard deviations of the extraction yield, total vitamin E, vitamin E 
components, scavenging DPPH capability, and degradation of alpha-tocopherol were reported 
from triplicate determinations for each sample. Two-way ANOVA using Proc Mixed 2x5 
factorial (SAS system, SAS Institute Inc., Cary, NC) was used to test significant differences 
among temperatures (40, 60, 80, 100, and 120ºC) and solvents (isopropanol and hexane) for 
microwave-assisted method. Two-way ANOVA using Proc Mixed 2x2 factorial was used to test 
significant differences among solvents (isopropanol and hexane) and extraction methods 
(microwave-assisted and conventional solvent extractions) at 40ºC. Multiple comparison tests 
were performed by using Tukey adjustment to determine the significant difference between 
treatments. Statistical significance was declared at P < 0.05. 
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2.4. Results and Discussions 
2.4.1. Rice Bran Oil Yield Extracted by Conventional Solvent and Microwave-assisted 
Extractions 
Rice bran oil yield extracted with isopropanol and hexane by conventional solvent and by 
microwave-assisted extractions is presented in Figure 2.2. The oil yield by microwave-assisted 
extraction at 40ºC was approximately 10% of the fresh rice bran for isopropanol and 
approximately 14% for hexane. By increasing the extraction temperature to 120ºC, the oil 
amount extracted was 50% higher when isopropanol was used as an extraction solvent (Table 
2.1.). For hexane, no significant change in the amount of oil extracted was noticed by increasing 
the extraction temperature from 40 to 120ºC (Table 2.1.). It seems that at higher temperatures the 
solubility of rice bran oil in isopropanol increased and maybe more polar components were 
extracted such as alcohol soluble proteins and carbohydrates, increasing the amount of the oil 
extracted at these temperatures. The results are similar to those found by Duvernay et al. (2005), 
who showed a 54% increase in oil yield by increasing the temperature from 80 to 140ºC by 
microwave assisted method using isopropanol as extraction solvent. At 40ºC hexane extracted 
significant more amount of oil (0.14 g oil/g fresh rice bran) as compared with isopropanol (0.10 
g oil/g fresh rice bran) by microwave-assisted method, data similar with the results found by Hu 
et al (1996). At higher temperatures (100 and 120ºC) isopropanol proved to be a significantly 
better solvent for the extraction of rice bran oil as compared with hexane. 
The conventional solvent extraction at 40ºC for isopropanol yielded approximately 12% 
oil of the fresh rice bran, not significantly different from the oil yielded by microwave assisted 
extraction in the same conditions. The amount of oil extracted with hexane by conventional 
solvent extraction was approximately 14% which was similar with the amount of oil extracted 
with hexane by microwave-assisted extraction. These values were close to 14.95% oil yield 
extracted from rice bran by traditional solvent extraction using hexane as a solvent at ambient 
temperature by Proctor (1996). Hu et al. (1996) reported that approximately 19% oil from the 
fresh rice bran was extracted by hexane at 40 and 60ºC while isopropanol extracted 17 and 18% 
at 40 and 60ºC, respectively. The small differences in oil yield between different data reported in 
the literature and those found in this study can be explained by a number of factors that affect the 
rice and rice bran: storage conditions, rice, milling, rice bran stabilization, and the conditions 
used for extraction.  
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Figure 2.2. Oil yield obtained by conventional solvent and microwave-assisted methods using 
isopropanol and hexane as extraction solvents (I= isopropanol, H= hexane, ME= microwave-
assisted extraction, SE= conventional solvent extraction). n=6.  
2.4.2. Total Vitamin E and Vitamin E Components of Rice Bran Oil Extracted by 
Conventional Solvent and Microwave-assisted Solvent Extractions 
The amount of total vitamin E was expressed as the sum of all four components analyzed, 
α-tocopherol, α-tocotrienol, γ-tocopherol, γ-tocotrienol. By increasing the temperature from 40 to 
120ºC the total vitamin E varied between 95.41 and 152.31 µg/ g fresh rice bran when 
isopropanol was used as a solvent, difference which was not found statistically different (Table 
2.1.). When hexane was used as a solvent for the microwave extraction of vitamin E 
components, the total vitamin E increased, but not significantly from 56.22 to 98.19 µg/ g fresh 
rice bran by raising the temperature from 40 to 100ºC (Table 2.1.). A further increase in 
temperature to 120ºC provided a significant increase in the total vitamin E to 248.50 µg/ g fresh 
rice bran. The average total extracted vitamin E was significantly greater when hexane was used 
as a solvent as compared to isopropanol, for extractions performed at 120ºC. The total vitamin E 
obtained by conventional solvent extraction at 40ºC was 87.46 µg/ g fresh rice bran for 
isopropanol and 52.64 µg/ g fresh rice bran for hexane. These values are similar with the total 
vitamin E amount extracted in the same conditions by microwave-assisted extraction method 
(Figure 2.3.). 
The variations of the amount of each vitamin E component with temperature for 
microwave-assisted extraction are presented in Table 2.1. and for conventional solvent extraction 
the data is presented in Table 2.2. For microwave-assisted extraction an increase in temperature 
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from 40 to 100ºC produced an increase of 47.4% in the extraction of α-tocopherol (not 
significant). For hexane, no significant difference was noticed in the microwave-assisted 
extraction of α-tocopherol by increasing the temperature (Figure 2.4.). At 80 and 100ºC, 
isopropanol extracted significantly more α-tocopherol as compared with hexane, 127.18% and 
135.32% more α-tocopherol, respectively (Table 2.1.). No significant differences among the 
solvents and extraction methods were noticed related to α-tocopherol extracted (Table 2.2.). 
Variation of α-tocotrienol with temperature and solvent is presented in Figure 2.5. When 
isopropanol was used as a solvent in the microwave-assisted extraction an increase in 
temperature from 40 to 120ºC produced an increase in the extraction amount of α-tocotrienol 
from 8.19 to 54.50 µg/ g fresh rice bran, which statistically is not significantly different (Table 
2.1.). For hexane, the extraction amount of α-tocotrienol did not significantly increase between 
40 and 100ºC (from 9.07 to 45.99 µg/ g fresh rice bran) but an increase in temperature to 120ºC 
significantly raised the amount of α-tocotrienol to 183.76 µg/ g fresh rice bran (Table 2.1.). 
Hexane extracted significantly more α-tocotrienol as compared with isopropanol at 120ºC. No 
significant differences among the solvents and extraction methods were noticed for the extraction 
of α-tocotrienol (Table 2.2.). 
For γ-tocopherol, a significant change with temperature was noticed when isopropanol 
was used, from 5.37 to 7.29 µg/ g fresh rice bran for 40 and 120ºC, respectively (Figure 2.6.). 
When hexane was used as extraction solvent no significant change in the amount of γ-tocopherol 
was noticed as a function of temperature (Table 2.1.). In terms of the extraction method, at 40ºC, 
for both microwave-assisted and conventional solvent extractions, isopropanol extracted 
significantly more γ-tocopherol as compared to hexane (Table 2.2.). Also, for microwave-
assisted extraction performed in the temperature range of 80 to 120ºC, isopropanol proved to be 
a significantly better extraction solvent for γ-tocopherol as compared with hexane (Table 2.1.). 
The amount of γ-tocotrienol did not vary significantly with temperature when 
isopropanol was used as an extraction solvent. When hexane was used, a significant increase in 
γ-tocotrienol was noticed by raising the temperature in the range 40 to 60ºC, from 17.36 to 29.31 
µg/ g fresh rice bran (Figure 2.7.). At 40ºC, both microwave-assisted and conventional solvent 
extractions with isopropanol extracted significantly more γ-tocotrienol as compared to hexane 
(Table 2.2.). The extraction performed in the temperature range 80 to 120ºC by microwave-
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assisted method with isopropanol was proved to significantly extract more γ-tocotrienol as 
compared with microwave-assisted with hexane (Table 2.1.). 
The optimum microwave-assisted extraction of α-tocopherol was accomplished  at an 
extraction temperature of 100ºC when isopropanol was used as a solvent. Microwave-assisted 
extraction at 120ºC with hexane produced a very large yield of α-tocotrienol. The higher 
extraction temperature and microwave energy may release some free forms of tocopherols which 
were previously in esterified forms. This may explain the high extraction of α-tocotrienol at an 
elevated temperature by hexane. 
 
 
Table 2.1. Oil yield, total vitamin E, vitamin E components, scavenging DPPH capability as 
a function of temperature using microwave-assisted extraction and solvent type 
 
 
I= Isopropanol; H= Hexane;  
1 Oil yield was expressed as g/ g fresh rice bran; 
2 Total vitamin E and vitamin E components were expressed as µg/ g fresh rice bran; 
3 Scavenging DPPH capability was expressed as Trolox Equivalent µmol/ g fresh rice bran. Significantly different 
values (P<0.05) of oil, vitamin E, vitamin E components, and scavenging DPPD capability in the same column are 
indicated by different letters a,b,c,d.  n=3. 
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Table 2.2. Oil yield, total vitamin E, vitamin E components, scavenging DPPH capability as 
a function of solvent type using microwave-assisted and conventional solvent extractions at 40ºC 
 
1 Oil yield was expressed as g/ g fresh rice bran; 
2 Total vitamin E and vitamin E components were expressed as µg/ g fresh rice bran; 
3 Scavenging DPPH capability was expressed as Trolox Equivalent µmol/ g fresh rice bran. Significantly different 
values (P<0.05) of oil, vitamin E, vitamin E components, and scavenging DPPD capability in the same column are 
indicated by different letters a,b,c,. n=3. 
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Figure 2.3. Total vitamin E extracted by conventional solvent and microwave-assisted 
methods using isopropanol and hexane as extraction solvents (I= isopropanol, H= hexane, ME= 
microwave-assisted extraction, SE= conventional solvent extraction). n=3. 
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Figure 2.4. Alpha-tocopherol extracted by conventional solvent and microwave-assisted 
methods using isopropanol and hexane as extraction solvents (I= isopropanol, H= hexane, ME= 
microwave-assisted extraction, SE= conventional solvent extraction). n=3. 
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Figure 2.5. Alpha-tocotrienol extracted by conventional solvent and microwave-assisted 
methods using isopropanol and hexane as extraction solvents (I= isopropanol, H= hexane, ME= 
microwave-assisted extraction, SE= conventional solvent extraction). n=3. 
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Figure 2.6. Gamma-tocopherol extracted by conventional solvent and microwave-assisted 
methods using isopropanol and hexane as extraction solvents (I= isopropanol, H= hexane, ME= 
microwave-assisted extraction, SE= conventional solvent extraction). n=3.  
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Figure 2.7. Gamma-tocotrienol extracted by conventional solvent and microwave-assisted 
methods using isopropanol and hexane as extraction solvents (I= isopropanol, H= hexane, ME= 
microwave-assisted extraction, SE= conventional solvent extraction). n=3. 
2.4.3. Free Radical Quenching Capability of Rice Bran Oil Extracted by Conventional 
Solvent and Microwave-assisted Extractions 
 The results on free radical quenching capability of rice bran oil antioxidants obtained by 
conventional solvent and microwave-assisted extractions are presented in Figure 2.8. When 
isopropanol was used as a solvent, the free radical quenching capability increased significantly 
by increasing the temperature of microwave-assisted extraction, from 33.61 to 59.85 µmol 
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Trolox Equivalent per gram of fresh rice bran for 40 and 120ºC, respectively. The free radical 
quenching capability did not change significantly for the oil extracted with hexane by 
microwave-assisted extraction (Table 2.1.). The change in antioxidant activity of the rice bran oil 
followed a similar trend to that of the amount of oil extracted as a function of temperature. This 
suggests that the amount of total phenolic extracted compounds, which are soluble in methanol, 
may be correlated with the antioxidant activity. At 120ºC, the rice bran oil extracted with 
isopropanol presented a significant higher DPPH scavenging capacity in comparison with rice 
bran oil extracted with hexane. This can be explained by the higher miscibility of isopropanol 
with the rice bran oil at higher temperatures, which led to more antioxidants extracted at elevated 
temperatures. Since oryzanol is soluble in alcohols, maybe isopropanol at higher temperature 
extracted more oryzanol components in the rice bran oil which provided an increase in the 
antioxidant activity of the oil. No significant different DPPH scavenging capacity was noticed 
between the two solvent when both microwave-assisted and conventional solvent methods were 
compared (Table 2.2.). It is important to note that the DPPH radical scavenging capacity was 
determined in methanol so only the antioxidant capacity of the components soluble in methanol 
was tested. 
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Figure 2.8. Capability of scavenging DPPH free radicals (Trolox Equivalent µmol/ g fresh 
rice bran) from rice bran extracted by conventional solvent and microwave-assisted methods 
isopropanol and hexane as extraction solvents (I= isopropanol, H= hexane, ME= microwave-
assisted extraction, SE= conventional solvent extraction). n=3.  
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2.4.4. Study of Degradation of α-tocopherol in the Microwave Extractor System at 
Elevated Temperature 
The results on degradation of α-tocopherol held at elevated temperature in the microwave 
extractor system is presented in Figure 2.9.a for α-tocopherol dissolved in isopropnaol and 2.9.b 
for α-tocopherol dissolved in hexane. No significant change in the amount of α-tocopherol 
during the process of microwave heating and evaporation was noticed. These findings are in 
agreement with the studies on the degradation of tocopherols and tocotrienols exposed to the 
environmental conditions (Mazza, 2002). Since microwave extraction and evaporation process 
were performed in dark conditions and in the presence of limited amount of oxygen for 
microwave extraction method, and under vacuum for the evaporation process, the exposure of 
the samples to light and oxygen was minimal. The most important factor in both processes 
(microwave heating and vacuum evaporation) was the elevated temperature. These results 
showed that during the whole extraction process α-tocopherol was not degraded.  
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Figure 2.9. Study on degradation of α-tocopherol in the microwave extractor system at 
elevate temperature (a= isopropanol, b= hexane). Value C = control, Ev = evaporation effect, and 
MEv = microwave and evaporation effect. Error bars represent standard deviation of 3 replicates.  
 2.5. Conclusion 
For microwave-assisted extraction, hexane proved to be a better solvent for rice bran oil 
extraction as compared to isopropanol for extractions performed at 40ºC; hexane extracted 
approximately 40% more oil than isopropanol. While by increasing the temperature, hexane did 
not extract significantly more amount of oil, isopropanol extracted about 25% more rice bran oil 
at 120ºC than hexane in the same conditions. At higher temperature, isopropanol proved to be a 
better solvent for rice bran oil. Hexane extracted large amount of α-tocotrienol at 120ºC while 
the increase in temperature for isopropanol was more beneficial for the extraction of γ-
tocopherol. Also, isopropanol at higher temperature seems to extract more hydrophilic 
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antioxidants which were revealed in the 78% increase of DPPH scavenging capability by 
increasing the temperature from 40 to 120ºC. 
No significant differences in the oil yield, total vitamin E, and antioxidant activity of rice 
bran oil was noticed between the two extraction methods, conventional solvent and microwave-
assisted extractions, at 40ºC. The results showed that during the whole extraction process α-
tocopherol was not degraded.  
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CHAPTER 3. NANOPARTICLES WITH ENTRAPPED ALPHA-
TOCOPHEROL; SYNTHESIS, CHARACTERIZATION, AND 
CONTROLLED RELEASE  
3.1.  Introduction 
Encapsulation of alpha-tocopherol in polymeric nanoparticles can be achieved by a 
number of methods, including emulsion or microemulsion polymerization, interfacial or 
precipitation polymerization, emulsion evaporation, emulsion diffusion, solvent displacement 
and salting out. Many studies reported the use of emulsion evaporation method for nanoparticle 
preparation and entrapment of various drugs (Mainardes et al., 2005; Li et al., 2001; Mu and 
Feng, 2002; Muller,1990; Cascone et al., 2002; Birnbaum and Brannon-Peppas, 2003, Astete and 
Sabliov, 2006). The principle of this method is based on the emulsification of the organic phase 
in an aqueous phase; an oil in water (o/w) emulsion is formed with the organic phase (polymer 
and solvent) and the water phase, containing the surfactant. After the emulsification process, the 
solvent is evaporated resulting in the precipitation of the polymer and formation of nanoparticles. 
The emulsification process is a critical step in nanoparticles synthesis due to the direct 
relationship between the final size of particles and the emulsion droplets (Astete and Sabliov, 
2006).  Several synthesis parameters affect nanoparticle physical characteristics, which in turn 
will affect the release profile of the drug.  
3.1.1. Parameters Affecting the Size of Nanoparticles 
3.1.1.1. Solvent 
Two major criteria are taken into consideration for choosing the organic solvent to be 
used in the nanoparticles preparation: the solubility of PLGA in this solvent and the 
immiscibility of the solvent with the aqueous phase (Astete and Sabliov, 2006; Birnbaum and 
Brannon-Peppas, 2003).  The evaporation rate of the organic solvent also influences the 
formation of nanoparticles. It is very important that the evaporation of the solvent be performed 
in the shortest time; otherwise, a small decrease in solvent volume increases the viscosity of the 
droplets and causes coalescence of the particles. Vacuum rotative evaporator provided particles 
with smaller diameter than those obtained by magnetic stirring (Mainardes et al., 2005; Brannon-
Peppas et al., 1995).  
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3.1.1.2. Organic to Aqueous Ratio 
The increase of internal to external phases ratio (organic to aqueous ratio) provided a 
small decrease in nanoparticles size as a result of preventing the agglomeration of particles by 
using more organic solvent (Mainardes et al., 2005). 
3.1.1.3. Polymer 
In order to avoid chronic toxicity caused by the accumulation of nonbiodegradable 
polymers into the body, biodegradable polymers are preferred for synthesis of nanoparticles 
designed for pharmaceutical or food use (Niwa, 1993; Uhrich, 1999). Many biodegradable 
polymers can be used for micro- and nanoparticles synthesis, of which most frequently used are 
polylactic acid (PLA) and poly(lactic acid-co-glycolic acid) (PLGA). These polymers have been 
FDA approved for drug delivery (Birnbaum and Brannon-Peppas, 2003; Brannon-Peppas, 1995; 
Ghosh, 2004). High molecular weight nondegradable polymers with a molecular weight bigger 
than the capacity of glomerular filtration can not be excreted through the kidney (Yoo, 2000). 
Utilization of PLGA as drug delivery systems is based on its capacity to biodegrade into 
biologically safe products through natural biological processes (Mainardes, 2005; Birnbaum and 
Brannon-Peppas, 2003). An advantage of PLGA, besides the fact that is degradable into non-
toxic compounds, is represented by the release rate of the drug which can be controlled by 
changing the ratio of the monomers in the co-polymer (Yoo, 2000). The amount of polymer used 
in synthesis of nanoparticles affects their size, shape, and agglomeration tendency. An increase 
in the amount of PLGA from 12.5 to 50 mg resulted in nanoparticles of a non-spherical shape of 
bigger size, which had the tendency to agglomerate (Mainardes et al., 2005).  
3.1.1.4. Surfactant 
 The surfactant prevents the coalescence of particles and plays a crucial role in the 
emulsification step, and in droplet protection and stabilization. An increase in the surfactant 
concentration results in decreasing the particles diameter and narrowing the granulometric 
distribution. At low concentration of surfactant the stabilization of particles is difficult and 
agglomeration is present (Mainardes et al., 2005). 
 The type of surfactant is important for synthesis of stable and small nanoparticles. 
Surfactants such as PVA, SDS, Pluronic F68 are commonly used in the nanoparticles synthesis 
(Astete and Sabliov, 2006; Kim and Burgess, 2002; Lee et al., 2002; Mainardes and Evangelista, 
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2005). For the application of the nanoparticles in the biomedical field, the presence of a toxic 
surfactant residue on the particles surface must be avoided. For this reason, many research 
studies are concentrated on finding biodegradable and biocompatible surfactants that can be used 
in nanoparticles preparation (Astete and Sabliov, 2006).  
PVA is widely used as an emulsifier in the synthesis of nanoparticles of a relatively small 
size and uniform size distribution. Residual PVA associated to the surface of particles, formed as 
a result of interconnected network between PVA and polymer, following purification could be up 
to 13% (w/w), relative to the weight of nanoparticles (Sahoo, 2002). The residual PVA 
associated to the surface of nanoparticles has a significant influence on nanoparticles size, zeta 
potential, polydispersity index, surface hydrophobicity, drug loading and drug release, and 
nanoparticles cellular uptake (Sahoo, 2002). The amount of residual PVA on the surface of 
particles is a function of the initial concentration of PVA and of the type of organic solvent used 
for the nanoparticle synthesis (Sahoo, 2002). 
3.1.1.5. Drug Content 
The increase in drug content causes an increase in particles size and size distribution due 
to higher viscosity of the dispersed phase (Mainardes et al., 2005). Redhead et al., (2001) studied 
the effect of the drug loaded on the physical characteristics of PLGA nanopaticles. The particles 
loaded with hydrophilic drugs (~ 150 nm) were slightly bigger than PLGA nanoparticles without 
entrapped drug (~ 135 nm). They confirmed that PLGA nanoparticles were more polar while 
polystyrene nanoparticles were more hydrophobic. This characteristic of the polymers can be 
used to design nanospheres with a desired released profile. The affinity of the drugs for different 
polymers provides the means to control the drug release rate from the polymer matrix.  
3.1.1.6. Sonication  
 Sonication time is very important in making a microemulsion. If the phase is not 
sufficiently dispersed, and the emulsion droplets are big, bigger nanoparticles are obtained. The 
study of how shape and size distribution of nanoparticles changes as a function of sonication 
time revealed the following: the particles were spherical for all situations; while the sonication 
time increased, the mean diameter of nanoparticles was reduced, the granulometric distribution 
was narrower and the profile of distribution was monomodal for the highest sonication time (20 
min) as per Mainardes et al. (2005). The explanation of this phenomenon was that the highest 
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energy released during sonication caused a fast dispersion of the organic phase, leading to the 
formation of small nanodroplets of a monomodal distribution. However, Lee et al. (2002) 
showed that sonication provided a lower encapsulation efficiency in comparison with that 
obtained using high-pressure homogenization. 
3.1.1.7. Storage/ Resuspension 
 Following synthesis, the size of the nanoparticles is affected by aggregation. De and 
Robinson (2004) studied the effect of storage and temperature on morphology and stability of 
PLGA nanoparticles. Their interest was also to check if the particles aggregated after 
resuspension in water. The study was conducted over a period of 6 days at temperatures between 
4 and 50ºC. Aggregation increased with an increase in storage temperature and it was more 
pronounced for the smaller nanoparticles. When the quantity of lactic acid in the copolymer 
increased, the extent of aggregation decreased. Three mechanisms were proposed to explain the 
aggregation of nanopaticles: a) after storage at elevated temperatures the PVA which forms a 
corona on the particles surface was affected by temperature and destabilized, resulting in 
aggregation; b) at high temperatures dichloromethane (the solvent) migrated to the surface 
dissolving the PLGA which was conducive to aggregation of particles; c) the type of drug 
entrapped did not affected the aggregation of nanoparticles (similar aggregation occurred for 
both Bodipy and Paclitaxel). All these suppositions were not confirmed, the only important 
recommendation to avoid irreversible aggregation was to store the formed nanospheres at 4ºC in 
desiccators. 
3.2. Entrapment Efficiency  
In general, the larger size nanoparticles present a higher drug loading capacity per 
particle (Muller, 1990). Hydrophobic drugs are entrapped easier and with much higher 
entrapment efficiency (usually greater than 90%) than hydrophilic drugs. This behavior is caused 
by the high solubility of the hydrophobic compound in the organic solvent (Birnbaum and 
Brannon-Peppas, 2003). The entrapment efficiency of hydrophilic drugs is low because of the 
drug lost in the aqueous phase during the emulsification process (Redhead, 2001; Birnbaum and 
Brannon-Peppas, 2003). Another reason for the low encapsulation efficiency of hydrophilic 
drugs is the smaller size of the particles and the short diffusion pathway (Redhead, 2001).  The 
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entrapment efficiency of the drug can also be affected by the type of polymer in which the drug 
is incorporated. Li et al. (2001) reported that PEG-PLGA nanoparticles present a lower 
encapsulation efficiency of bovine serum albumin (48.6%) in comparison with PLGA 
nanoparticles (63.8%). Emulsifiers with a HLB (hydrophilic-lipophilic balance) value higher 
than 15 (tween 80 and tween 20) enhance the entrapment efficiency of naltrexone HCl by 
modifying the surface properties of the particles (Dinarvand et al., 2005). 
3.3. Release Profile 
In the past years, many studies were reported on the release profile of different 
hydrophobic drugs (Mainardes et al., 2005; Lee et al., 2002; Cascone et al., 2002; Yeo and Park, 
2004; Dingler et al., 1999; Duclairoir et al., 2002; Mu and Feng, 2002) and hydrophilic drugs 
(Redhead et a., 2001; Niwa et al., 1993) encapsulated in PLGA. Two mechanisms by which the 
drug is released from nanoparticles were identified. One of these mechanisms was the diffusion 
of the drug through the polymer matrix, and the other was the erosion of the matrix as a result of 
the polymer degradation (Lee, 2002).  
A comparison between the release profile of poorly water-soluble drugs and hydrophilic 
drugs revealed an initial burst in the release of water-soluble drugs, even when high-molecular-
weight polymers were used for the drug entrapment. The fast release of water-soluble drug could 
be attributed to the higher affinity of the drug for the release medium, water (Niwa et al., 1993). 
An initial burst release of the drug from nanospheres is not optimum for utilization of 
nanoparticles in some medical applications, whereas in others it may be preferred (Niwa et al., 
1993).  
There are a number of factors that affect the release profile of the drugs entrapped in the 
nanoparticles: 
3.3.1. Size of Nanoparticles 
The size of the particles plays an important role in the release profile of the entrapped 
drugs. In general, the drugs entrapped in small particles (nanoparticles) were released faster and 
more constantly than those incorporated in bigger particles (microspheres) (Niwa et al., 1993). 
This was caused by the higher surface area per volume ratio of nanoparticles. Also, the small 
diffusion distance characteristic to nanoparticles is allowing for rapid release of the drug from 
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the core into the medium (Redhead et al., 2001; Niwa et al., 1993). This behavior was noticed for 
hydrophobic (Lee et al., 2002) and hydrophilic drugs (Redhead et al., 2001).  Lee et al. (2002) 
studied the release profile of Cyclosporin A, a highly hydrophobic cyclic peptide, entrapped in 
PLGA matrix by solvent evaporation method. The drug release profile determined by RP-HPLC 
showed that the drug was released primarily as a result of diffusion as opposed to matrix erosion.  
3.3.2. Characteristic, Molecular Weight, and Ratio of Monomers in the Polymer 
The polymer characteristics used as a matrix for the entrapment of a drug influence the 
release rate of this compound (Birnbaum and Brannon-Peppas, 2003; Yeo and Park, 2004; Niwa 
et al., 1993). PLGA with a high molecular weight is degraded slower than the low molecular 
weight PLGA. For the drugs encapsulated into low-molecular-weigh polymer an initial burst was 
observed; increasing the molecular weight of the polymer resulted in a significantly lower burst. 
The rigid matrix of the high-molecular-weight polymer permits a slower diffusion of the drug 
through the matrix as compared to low-molecular-weight polymer (Niwa et al., 1993).  
Implicitly, the release rate is more sustained for high molecular weight PLGA.  
It is well established in the literature that the degradation of PLGA is by bulk erosion. 
The release rate of the drug from the polymer matrix can be controlled by changing the ratio of 
the monomers in the co-polymer (Yoo, 2000). PLGA 85/15 and PLA are more hydrophobic than 
PLGA 50/50 (Lee, 2002) as a result of the higher hydrophilicity of the glycolil units in 
comparison with lactil units. Different diffusion rates of the aqueous phase into the polymer 
matrix were seen as a result of a different lactic to glycolic ratio in the co-polymers (Cascone et 
al., 2002). An increase in the glycolil units in the copolymer it will increase the absorption of 
water in the polymer matrix (Cascone, 2002). If the concentration of lactide is higher in the 
copolymer, the release of the drug is lower, possible due to the hydrophobic interaction between 
the polymer and the drug (Lee et al., 2002). 
3.3.3. Type of the Drug Entrapped into the Nanoparticles 
In general, the release profile of hydrophilic compounds shows a strong initial burst 
followed by a fast release of the drug, while for the hydrophobic compounds the release profile is 
much slower and more constant. The release of the drugs from nanoparticles depends on the 
nature of interactions between the drug and the polymer and on the affinity of the drug for the 
release medium (Birnbaum and Brannon-Peppas, 2003). 
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3.3.4. Ratio Polymer to Drug in the Nanoparticles 
The amount of drug entrapped in the particles can affect the release rate. An increase in 
the drug amount in the nanoparticles results in an increase of the release rate for both 
hydrophobic (Mainardes et al. 2005) and hydrophilic drugs (Birnbaum and Brannon-Peppas, 
2003). Mainardes et al. (2005) showed that the release of praziquantel (hydrophobic drug) in 
time was faster when the amount of drug entrapped was higher. The smaller the entrapped drug 
quantity the more uniformed the release was. 
3.3.5. Freeze-drying 
Yeo and Park (2004) studied the in vitro release profile of lysozyme after it was 
encapsulated in PLGA matrix with and without freeze-drying. The release test was performed for 
microcapsules suspended in the release medium. The microcapsules showed a different release 
profile depending on whether they were previous dried or not. Freeze-drying process appeared to 
induce damage, compromising the physical integrity of the microcapsules, and therefore 
affecting the release profile.  
3.3.6. Release Medium 
Many studies reported the use of phosphate buffered saline (PBS) as a release medium 
for PLGA loaded nanoparticles (Mu and Feng, 2002; Mu and Feng, 2003; Yoo et al., 2000; Mu 
and Feng, 2003a; Cascone et al., 2002; Redhead et al., 2001; Birnbaum and Brannon-Peppas, 
2003; Sansdrap and Moes, 1997; Lamprecht et al., 2001; Niwa et al., 1993; Fonseca et al., 2002). 
Non-toxic surfactants were added to the release medium in order to increase the release rate of 
highly hydrophobic compounds. Tween 80 was added to the phosphate buffer release medium to 
increase the release of cyclosporin A from the PLA and PLGA nanoparticles (Lee et al., 2002) or 
of amoxicillin from PLGA microspheres (Kim and Burgess, 2002). Tween 80 was also added to 
PBS medium in which PEG-PLGA nanoparticles loaded with a protein were placed (Li et al., 
2001). 
3.3.7. Additives 
A few methods for improving the release of drugs from PLGA microparticles were 
mentioned, especially for highly hydrophobic drugs. The addition of additives such as isopropyl 
myristate or sucrose, to the release medium accelerated the release of hydrophobic drugs. In vitro 
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release of taxol from PLGA matrix was increased by adding isopropyl myristate which changed 
the microparticle matrix allowing the formation of channels, which allowed for a faster diffusion 
of the drug from the microparticle (Birnbaum and Brannon-Peppas, 2003). Fatty acid esters 
added increased the release rate of hydrophobic drugs by solubilizing the drug and passing it 
trough these channels (Lee et al., 2002). Lee et al. (2002) studied the PLGA nanoparticles loaded 
with dexamethasone and entrapped into PVA hydrogels to establish the release profile of the 
drug. No important change in the release profile of the drug was observed by incorporating the 
nanoparticles into the PVA matrix. 
Redhead et al., (2001) studied the release of Rose Bengal from PLGA nanoparticles. 
PLGA nanoparticles under 250 nm in size were coated with copolymers of the poloxamer and 
poloxamine series. Coating the particles with these copolymers minimized their capture by 
macrophages in vitro and in vivo, which lead to an increase in their life-time in the circulation 
system. The drug loading into these coated nanoparticles was a little higher than drug loading in 
uncoated particles. This behavior was attributed to the presence of the surfactant on the 
nanoparticles surfaces which adsorbed more drug into the matrix. The release profile observed 
was biphasic, showing an initial burst, as a result of the release of the drug present at the surface, 
followed by a slower release of the drug entrapped inside the PLGA matrix, by diffusion. Half of 
the drug entrapped in these coated particles was released in 10 hours.  
3.4. Objectives  
1. Synthesis of poly (D,L-lactide-co-glycolide) nanoparticles with entrapped α-tocopherol 
by emulsion evaporation method, with PVA as surfactant. 
2. Characterization of PLGA(αT) nanoparticles in terms of morphology (TEM), size, size 
distribution, and zeta potential (DLS), and entrapment efficiency (HPLC).  
3. Study of the release of α-tocopherol from the PLGA(αT) nanoparticles. 
3.5. Materials and Methods 
3.5.1. Chemicals and Materials 
 Poly(DL-Lactide-co-Glycolide) (PLGA) 50:50 with an average molecular weight of 
45,000-75,000, poly(vinyl alcohol) (PVA) with an average molecular weight of 30,000-
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70,000, α-tocopherol 95%, boric acid 99.99%, iodine puriss p.a., and potassium iodide, 99.99% 
were purchased from Sigma Aldrich (Sigma Chemical Co, St Louis, MO). Dichloromethane, 
ethyl acetate, and acetonitrile were obtained from EMD (EMD Chemicals Inc., Gibbstown, NJ). 
Sodium hydroxide and sodium chloride were acquired from Fisher Scientific (Fisher Scientific, 
Fair Lawn, NJ), hydrochloric acid 1.0 N was obtained from VWR International (VWR 
International, West Chester, PA), and sodium dodecyl sulfate (SDS) (20% w/v) was purchased 
from Amresco (Amresco Inc., Solon, OH). Nanopure water was obtained using Nanopure 
Diamond (Barnsted International, Dubuque, Iowa) and 0.2 µm Barnsted D3750 Hollow Fibre 
Filter. 
 3.5.2. Synthesis of Nanoparticles with Entrapped α-tocopherol 
Synthesis and characterization of nanoparticles were studied in triplicate and the release 
profiles of α-tocopherol in aqueous medium were studied in duplicate. Two concentrations of α-
tocopherol, 8 and 16% w/w (relative to PLGA), were incorporated into the PLGA matrix. 
Unloaded PLGA nanoparticles were synthesized and they were used as control systems. Two 
types of nanoparticles were prepared using two surfactants, PVA and SDS, by emulsion 
evaporation method in the following ways: 
a) Synthesis of Nanopaticles with SDS as a Surfactant 
PLGA nanoparticles with entrapped α-tocopherol and SDS as an emulsifier were 
synthesized by emulsion evaporation method as follows. The organic phase was formed by 
dissolving 125 mg PLGA and α-tocopherol in 2.5 ml ethyl acetate. Two α-tocopherol 
concentrations were studied: 8% and 16% w/w (reported to PLGA). The organic phase was 
added to 2 mg/ml  aqueous SDS solution (in nanopure water saturated with ethyl acetate) and 
emulsified with the homogenizer (Ultra Turrax T 18, IKA Works Inc., Wilmington, NC) for 3 
min at 12,000 RPM. The emulsion was sonicated in an ice bath at 4˚C with a probe-type 
sonicator set at 750 W (VC505, Sonics & Materials Inc., Newtown, CT) for 10 min, in pulse 
mode and an amplitude of 38%. The ethyl acetate was evaporated under vacuum (40 mmHg) and 
nitrogen flow (100 ml/min) for 7 min in a rotovapor (Buchi R-124, Buchi Analytical Inc., New 
Castle, DE) (Astete and Sabliov, 2006). Unloaded nanoparticles were prepared following the 
same method, without adding the α-tocopherol.    
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b) Synthesis of Nanoparticles with PVA as a Surfactant 
Synthesis of nanoparticles with entrapped α-tocopherol was accomplished following the 
guidelines presented in Figure 3.1.  
 
 
 
 
Figure 3.1. Schematic diagram for synthesis of nanoparticles with entrapped α-tocopherol 
using PVA as a surfactant 
 
 
PLGA, α-tocopherol, DCM PVA 0.3% in aqueous 
solution  
Add organic phase 
into aqueous phase 
in droplets, mix for 
1 minute
Sonicate, 2 min, 
under cooling 
Evaporate solvent 
under vacuum and 
nitrogen for 10 min 
Purifiy and freeze-
dry 
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The organic phase was formed by dissolving 50 mg of PLGA in 2 ml dichloromethane. 
Two α-tocopherol concentrations were studied, 8% and 16% w/w (reported to PLGA); α-
tocopherol at these concentrations was dissolved in dichloromethane. An aqueous phase was 
formed with 0.3% polyvinyl alcohol in nanopure water. The organic phase was added in droplets 
to the aqueous phase, and the emulsion was formed under homogenization (Ultra Turrax T 18, 
IKA Works Inc., Wilmington, NC) for 1 min at 10,000 RPM. The emulsion was sonicated in an 
ice bath at 4˚C with a probe-type sonicator of 750 W (VC505, Sonics & Materials Inc., 
Newtown, CT) for 2 min, in pulse mode at 38% amplitude. Dichloromethane was evaporated 
under vacuum (40 mmHg) and nitrogen flow (100 ml/min) for 10 min in a rotoevaporator (Buchi 
R-124, Buchi Analytical Inc., New Castle, DE) (Mainardes and Evangelista, 2005). Unloaded 
nanoparticles were prepared following the same method, without adding α-tocopherol to the 
organic solvent and they were used as a control system. Following synthesis, nanoparticles were 
purified by diafiltration to remove the excess α-tocopherol and surfactant. A GE Healthcare 
MidJet labscale membrane separations system with MidGee HOOP Cartrige H22LA of 1 µm 
pore size (Amersham Biosciences Corporation, Westborough, MA) was used for this purpose. 
The purification process was realized during one hour at 23 psgi inlet pressure and 18 psgi outlet 
pressure. After purification, nanoparticles were kept for two hours at - 80˚C and freeze-dried at - 
41˚C under 110 mmHg of vacuum for 48 hours in a freezone 4.5 (Labconco Corporation, Kansas 
City, MO). Trehalose was added to the nanoparticles suspension before precooling at a ratio of 
1:1 (w/w) relative to the amount of nanoparticles. Finally, the lyophilized samples were stored in 
desiccators placed in the refrigerator for further use.    
3.5.3. Characterization of Nanoparticles with Entrapped α-tocopherol  
Size, Size Distribution, and Zeta Potential 
Nanoparticles were characterized in terms of size, size distribution, and zeta potential by 
dynamic light scattering (DLS) using the Malvern Zetasizer Nano ZS (Malvern Instruments Inc., 
Southborough, MA). Size and PDI measurements were made for freshly synthesized 
nanoparticles (prior to purification), for purified nanoparticles, and for resuspended 
nanoparticles. In all cases, a volume of 1.3 ml of each sample at a concentration of 0.3 mg/ml 
was placed in a polystyrene cuvette and the measurements were performed at 25ºC. The 
viscosity and refraction index was set to those specific to water. Zeta potential was measured 
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with a disposable capillary cell with a volume of 1 ml after purification. The mean values of size 
and PDI were determined using a mono-modal distribution. 
Nanoparticle Morphology 
The morphology of the nanoparticles was studied by Transmission Electron Microscopy 
(TEM) using a JEOL 100-CX (JEOL USA Inc., Peabody, MA) system. One droplet of the 
aqueous phase containing nanoparticles was placed on a copper grid of 400 mesh with carbon 
film. The excess of sample was removed with a filter paper. Uranium acetate 2% was used as a 
stain; the excess uranium acetate was removed after 1 min with a filter paper. The sample was 
dried before analysis by TEM.   
Entrapment Efficiency  
The entrapment efficiency of α-tocopherol in the PLGA nanoparticles was measured by 
reverse phase high-performance liquid chromatography (RP-HPLC). A sample of 2 mg 
lyophilized nanoparticles was dissolved in 2 ml acetonitrile:water (95:5). One milliliter of each 
sample was centrifuged with an Allegra 64R Centrifuge (Beckman Coulter, Fullerton, CA) at 
30,000 RPM for 15 min in order to separate any solid residual. The entrapment efficiency of 
alpha-tocopherol was determined by injecting 25 µL of previous prepared sample into the HPLC 
column. The mobile phase used was acetonitrile: water: acetic acid in a ratio of 95:5:0.01 at a 
flow rate of 1.5 ml/min and a total run time of 20 min/sample. The column used was Discovery 
C18, 25 cm x 4.6 mm, 5 µm (Supelco, Sigma-Aldrich Corp., St. Louis, MO, USA), and the 
detector was a Waters 474 Scaning Fluorescence Detector (Waters Corporation, Milford, MA). 
The excitation wavelength was set at 290 nm and the emission wavelength at 320 nm. A standard 
curve was prepared under the same conditions. Chromatograms were recorded and processed 
using a Millennium 32 chromatography software. Alpha-tocopherol entrapment efficiency was 
expressed as percentage of the alpha-tocopherol entrapped into the nanoparticles reported to the 
initial amount of alpha-tocopherol used for nanoparticles preparation. 
3.5.4. Determination of the Residual PVA Associated to the Nanoparticles Surface  
 The residual PVA associated with the nanoparticles was determined by a colorimetric 
method based on the formation of a colored complex between iodine and two adjacent hydroxyl 
groups of PVA (Sahoo et al., 2002). Typically, 3 mg of lyophilized nanoparticles were dissolved 
in 2 ml nanopure water. Two milliliters of sodium hydroxide 0.5 M were added and the mixture 
 44
was kept on a water bath at 60ºC for 15 min. For neutralization of each sample, 0.9 ml  
hydrochloric acid 1 N was added and the volume was adjusted to 7 ml with nanopure water. 
Three milliliters of 0.65M boric acid were added to each sample together with 0.5 ml of a I2/KI 
solution (0.05M/0.15M). The final volume was adjusted to 12 ml with water. The absorbance of 
the samples was measured with a UV-Visible Beckman Coulter spectrophotometer (Beckman 
Coulter, Fullerton, CA) after 15 min of incubation at room temperature at 690 nm. A standard 
curve for PVA was prepared under the same conditions. 
3.5.5. Controlled Release  
 Lyophilized nanoparticles were dissolved in the release medium, containing 0.1 M 
SDS/0.1 M NaCl, at a concentration of 1 mg/ml; the sample was divided in 10 samples of 1 ml. 
The controlled release study was performed at 37˚C and 100 RPM in an incubator shaker C25 
KC (New Brunswick Scientific Inc., Edison, NJ). At predetermined time intervals, samples were 
withdrawn and centrifuged with an Allegra 64R Centrifuge (Beckman Coulter, Fullerton, CA) at 
30,000 RPM for 15 min in order to settle the nanoparticles. After the removal of the supernatant 
which contained the alpha-tocopherol released, the nanoparticles were dissolved in the mobile 
phase and centrifuged at 30,000 rpm for 15 min. The supernatant containing the solvent with 
alpha-tocopherol was analyzed by reverse-phase HPLC. The mobile phase was 
acetonitrile:water:acid acetic in the ratio  95:5:0.01, the injected volume was 50 µl and the flow 
rate 1.5 ml/min. The column used was Discovery C18 25 cm x 4.6 mm, 5 µm (Supelco, Sigma-
Aldrich Corp., St. Louis, MO, USA), and the detector was Waters 474 Scaning Fluorescence 
Detector (Waters Corporation, Milford, MA).  
3.5.6. Statistical Analysis 
 The experimental data for size and PDI of nanoparticles was analyzed by two-way 
ANOVA using Proc Mixed procedure (SAS system, SAS Institute Inc., Cary, NC). The 
experiment was designed as a two-factor (alpha-tocopherol theoretical loading and the 
processing parameters after synthesis) treatment structure with three levels for each factor. 
Multiple comparison tests were done by Tukey’s adjustment to determine the significant 
difference between treatments at P<0.05. The experimental data for residual PVA associated to 
nanoparticles, entrapment efficiency of alpha-tocopherol in the nanoparticles, and nanoparticles 
zeta potential were analyzed by one-way ANOVA using Proc Mixed procedure (SAS system, 
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SAS Institute Inc., Cary, NC). Multiple comparison tests were done by Tukey-Kramer 
adjustment to determine the significant difference between treatments at P<0.05. 
3.6. Results and Discussion  
3.6.1. Characterization of Nanoparticles  
 Morphology of Prepared Nanoparticles 
 The nanoparticles with entrapped alpha-tocopherol revealed a spherical shape with a 
narrow size distribution for nanoparticles prepared with different surfactants, SDS (Figure 3.2.) 
or PVA (Figure 3.5.), for the two alpha-tocopherol concentrations tested 8% (Figure 3.3, Figure 
3.4.) and 16% (Figure 3.6., and Figure 3.7.). 
 The TEM pictures of 8 and 16% α-tocopherol theoretical loaded nanoparticles prepared 
with SDS as an emulsifier showed a good distribution and small nanoparticle sizes (Figure 3.3. 
and Figure 3.4.). The higher density of SDS synthesized nanoparticles observed in the pictures 
can be explained by their smaller size and higher amount of the initial components, as compared 
to the PVA synthesized nanoparticles. The initial amount of PLGA in the solvent was 50 mg/ml 
for SDS nanoparticles as compared with 25 mg/ml for PVA synthesized nanoparticles. Also, the 
difference between the two types of surfactants; SDS is a small anionic compound with a high 
affinity for water whereas PVA is a high MW polymer less prone to leave the nanoparticles for 
the water, also explains the higher density of the SDS synthesized nanoparticles. 
 The TEM pictures of 8 and 16% α-tocopherol theoretical loaded nanoparticles prepared 
with PVA as a surfactant showed a good size distribution and a small nanoparticle size (Figure 
3.6. and Figure 3.7.); however, bigger nanoparticle sizes were observed as compared with those 
of SDS nanoparticles. A clear visual difference in size between SDS and PVA synthesized 
nanoparticles with entrapped α-tocopherol was noticed. No distinct difference was noticed 
however among the 0, 8, and 16% α-tocopherol theoretical loading for each surfactant. Also, the 
presence of PVA as a corona on the nanoprticles surface was visible in the TEM pictures; the 
corona was not noticed on the nanoparticles surface when prepared with SDS. The presence of α-
tocopherol in the polymeric matrix could not be determined by TEM. 
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Figure 3.2. TEM picture of nanoparticles prepared with SDS as an emulsifier with 0% alpha-
tocopherol theoretical loading 
 
 
   
Figure 3.3. TEM picture of nanoparticles prepared with SDS as an emulsifier with 8% alpha-
tocopherol theoretical loading 
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Figure 3.4. TEM picture of nanoparticles prepared with SDS as an emulsifier with 16% 
alpha-tocopherol theoretical loading 
 
 
 
Figure 3.5. TEM picture of nanoparticles prepared with PVA as an emulsifier  with 0% 
alpha-tocopherol theoretical loading 
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Figure 3.6. TEM picture for nanoparticles prepared with PVA as an emulsifier with 8% 
alpha-tocopherol theoretical loading 
 
 
 
Figure 3.7. TEM picture of nanoparticles prepared with PVA as an emulsifier with 16% 
alpha-tocopherol theoretical loading 
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Size and PDI of Nanoparticles 
Size and PDI (polydispersity index) for PVA nanoparticles was measured before and 
after purification, and after resuspension of lyophilized nanoparticles (Table 3.1.). For SDS 
nanoparticles, size and PDI was measured only after synthesis because of the difficulties in the 
purification step encountered as a result of the small size of the synthesized nanoparticles (Table 
3.2.).  
  For PVA nanoparticles, the size of freshly synthesized nanoparticles before purification 
decreased but not significantly with the entrapment of α-tocopherol in the PLGA matrix, from 
216.2 to 206.3 nm for 0% and 16% α-tocopherol theoretical loading, respectively (Table 3.1.). 
After purification by diafiltration, the size of nanoparticles increased slightly in all cases. The 
freeze-drying process caused an increase in the nanoparticles size with approximately 67 nm for 
nanoparticles  with 8% α-tocopherol theoretical loading, and with approximately 32 nm for 
nanoparticles with 16% α-tocopherol theoretical loading. For unloaded nanoparticles, the 
increase in size after freeze-drying was not significant (Figure 3.8.). As compared with PVA 
nanoparticles, the size of SDS nanoparticles before purification was much smaller, 71 nm for 
SDS unloaded nanoparticles versus 216 nm for PVA unloaded nanoparticles. This high 
difference in size can be explained by differences in synthesis method, but mostly by the type of 
surfactant used. PVA is a big molecule as compared with SDS, so the residual PVA attached to 
the nanoparticles surface can cause this increase in size for PVA nanoparticles. Moreover, SDS 
is an ionic surfactant more efficient in reducing the size of the emulsion droplets directly 
correlated with the nanoparticles size as compared to PVA. An important change in size was 
noticed for SDS nanoparticles with alpha-tocopherol entrapment. With the entrapment of α-
tocopherol in the PLGA matrix, the nanoparticles size decreased significantly from 71.2 nm for 
unloaded nanoparticles to 57.2 nm for nanoparticles with 8% α-tocopherol theoretical loading. 
By further increasing the amount of α-tocopherol theoretical loading to 16%, a further decrease 
in the size of nanoparticles was noticed (Table 3.2.). This behavior may be explained by the 
presence of α-tocopherol, which seems to accumulate on the nanoparticles surface and act as a 
co-surfactant together with SDS. 
 The PDI for PVA nanoparticles did not change significantly with the entrapment of α-
tocopherol in the polymeric matrix (Table 3.1.). The PDI was lower than 0.100 in all cases for 
the samples before purification. After purification by diafiltration, the PDI increased to 
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approximately 0.150. Important amounts of PVA were removed during the purification process 
and this could cause some agglomeration of nanoparticles. 
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Figure 3.8. Variation of size of PVA nanoparticles with α-tocopherol theoretical loading and 
processing parameters after synthesis. n=3. 
 After the freeze-drying process, the PDI change was not significant as compared with the 
PDI of nanoparticles before purification for unloaded nanoparticles, but it increased for the 
nanoparticles with 8% α-tocopherol theoretical loading from 0.093 to 0.239, and for 16% α-
tocopherol theoretical loading from 0.061 to 0.155 (Figure 3.9.). The PDI for SDS nanoparticles 
increased significantly with the entrapment of 8% α-tocopherol theoretical loading from 0.096 
for 0% α-tocopherol theoretical loading to 0.136 for 8% α-tocopherol theoretical loading (Table 
3.2.). A further increase of the α-tocopherol theoretical loading to 16% did not change the PDI 
significantly. Overall, the PDI for PVA nanoparticles before purification was smaller as 
compared with the PDI of SDS nanoparticles. 
Table 3.1. Size and PDI of nanoparticles as a function of α-tocopherol theoretical loading 
and processing parameters after synthesis. n=3. 
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Figure 3.9. Variation of PDI of PVA nanoparticles with α-tocopherol theoretical loading and 
processing parameters after synthesis. n=3.  
 
Table 3.2. Size and PDI of nanoparticles before purification as a function of α-tocopherol 
theoretical loading. n=3.  
SDS PVA aT theoretical loading (% 
w/w relative to PLGA Size (nm) PDI (au) Size (nm) PDI (au) 
0 71.2  ± 0.33a 0.096  ± 0.012a 216.2 ± 3.8a,b 0.083 ± 0.023a,b 
8 57.2  ± 0.28b 0.136  ± 0.015b 217.2 ± 12.8a,b 0.093 ± 0.012a,b 
16 53.6  ± 0.30c 0.150  ± 0.003b 206.3 ± 9.4a 0.061 ± 0.028a 
Significantly different values (P<0.05) of size and PDI in the same column are indicated by different letters a,b,c,.  
Zeta Potential of Nanoparticles 
Zeta potential is another important parameter in characterization of the nanoparticles. A 
highly negative or positive zeta potential indicates high repulsive forces and implicitly low 
probability for nanoparticles to agglomerate. Under these circumstances, a long-term stability of 
the nanoparticles can be expected. Zeta potential of the nanoparticles was negative for unloaded 
nanoparticles and for nanoparticles with entrapped α-tocopherol (Table 3.3.). This negative value 
was expected based on the presence of PVA at the surface of nanoparticles. With the entrapment 
of α-tocopherol in the polymeric matrix, zeta potential became less negative. It increased 
significantly from -28.67 mV for unloaded nanoparticles to -13.56 mV for nanoparticles with 8% 
α-tocopherol theoretical loading. By further increasing the α-tocopherol theoretical loading to 
16%, a not significant increase in zeta potential to -12.66 mV was noticed. 
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Table 3.3. Residual PVA associated with the nanoparticles, entrapment efficiency of α-
tocopherol, and zeta potential of the resuspended nanoparticles. n=3.   
aT theoretical loading 
(% w/w relative to 
PLGA) 
Zeta potential 
(mV) 
Entrapment efficiency 
(% of αT theoretical 
loading) 
Residual PVA (% w/w 
from nanoparticles) 
0 -28.67 ± 1.82a 0 5.09 ± 0.41a 
8 -13.56 ± 2.33b 89.63 ± 11.63a 6.80 ± 0.75a 
16 -12.66 ± 5.09b 95.59 ± 3.08b 7.16 ± 1.53a 
Significantly different values (P<0.05) in the same column are indicated by different letters a,b,c,.  
Entrapment Efficiency of α-tocopherol in the Nanoparticles 
Entrapment efficiency is used to indicate the amount of drug entrapped into the 
polymeric matrix. The entrapment efficiency of 8% α-tocopherol theoretical loading was 89.63% 
and by a further increase in the initial α-tocopherol to 16%, the entrapment efficiency increased 
to 95.59% (Table 3.3.). The more α-tocopherol was added to the organic phase the higher the 
entrapment efficiency. This is in agreement with the data found in the literature about 
hydrophobic components whose entrapment efficiency is usually greater than 90% (Birnbaum 
and Brannon-Peppas, 2003).  
Residual PVA Associated with the Nanoparticles 
The residual PVA associated with the nanoparticles has an important significance for the 
stability of nanoparticles, by preventing the nanoparticles to aggregate; the residual PVA also 
affects the release profile of the drug from the polymeric particles. The residual PVA associated 
with the nanoparticles after purification was 5.09% (w/w relative to the nanoparticles) for 
unloaded nanoparticles. For nanoparticles with 8% α-tocopherol theoretical loading the residual 
PVA was 6.80%, and for 16% α-tocopherol theoretical loading the residual PVA was 7.16% 
(Table 3.3.). 
3.6.2. Release Profile of α-tocopherol from PLGA Matrix 
The release profile was studied for nanoparticles loaded with 8 and 16% α-tocopherol 
theoretical loading and prepared with PVA as an emulsifier. The release profile of α-tocopherol 
from PLGA matrix in 0.1 M SDS/0.1 M NaCl at 37ºC was biphasic, showing an initial burst 
followed by a slower release of the drug entrapped inside the PLGA matrix. The release profile 
showed an initial burst effect in the first hour for both, 8 and 16% α-tocopherol theoretical 
loading (Figure 3.10.). The burst effect was higher for 8% α-tocopherol theoretical loading when 
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approximately 86% was released in the first hour followed by a constant release in the next 
hours. In 24 hours approximately 97% of α-tocopherol was released with 100% released in 48 
hours. The burst effect for 16% α-tocopherol theoretical loading was lower compared with that 
for 8% α-tocopherol theoretical loading. The burst effect noticed in the first hour was 
approximately 34% of the α-tocopherol determined at time zero. After the burst effect, the 
release profile for 16% α-tocopherol theoretical loading showed a uniform release in time. After 
7 hours approximately 67% of α-tocopherol was released from nanoparticles with approximately 
82% and 90% α-tocopherol released after 24 and 48 hours, respectively. The burst effect can be 
explained by the fast release of α-tocopherol found close to or attached to the surface of 
nanoparticles. The affinity of α-tocopherol to the release medium can be another reason for the 
fast release of α-tocopherol. The constant release profile that was noticed following the burst 
effect can be explained by the slow diffusion of α-tocopherol found inside the PLGA matrix. The 
release profile for nanoparticles prepared with SDS as an emulsifier was not studied because of 
the problems encountered during the purification step as a result of small nanoparticles sizes.  
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Figure 3.10. Release profile of α-tocopherol from PLGA matrix in 0.1 M SDS/0.1 M NaCl.  
3.7. Conclusion 
Emulsion evaporation method was a suitable technique for synthesis of spherical PLGA 
nanoparticles with a small size diameter, less than 100 nm for nanoparticles prepared with SDS 
as a surfactant, and about 200 nm for nanoparticles prepared with PVA as an emulsifier. For 
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nanoparticles prepared with SDS, the size of the nanoparticles significantly decreased with the 
entrapment of α-tocopherol in the PLGA matrix, from approximately 71 nm for unloaded 
nanoparticles to approximately 53 nm for nanoparticles with 16% α-tocopherol theoretical 
loading. For nanoparticles prepared with PVA, no significant change in the size of nanoparticles 
was noticed with the entrapment of α-tocopherol. The polydispersity index after synthesis was 
lower, under 0.100, for PVA nanoparticles, and around 0.150 for SDS nanoparticles. The 
polydispersity index for PVA nanoparticles increased during the purification step and during 
freeze-drying, but at all times it was not higher than 0.250. Zeta potential was negative for all 
nanoparticles prepared with PVA. The entrapment efficiency of α-tocopherol in the polymeric 
matrix was approximately 89% for nanoparticles with 8% α-tocopherol theoretical loading and 
approximately 95% for nanoparticles with 16% α-tocopherol theoretical loading. The residual 
PVA associated with the nanoparticles after purification was approximately 6% (w/w relative to 
the amount of nanoparticles) and it did not change with the amount of α-tocopherol entrapped. 
The release profile of α-tocopherol from PLGA matrix in the release media showed an initial 
burst effect followed by a more uniform release in the following hours. The release for 
nanoparticles with 8% α-tocopherol theoretical loading was faster with 86% release in one hour 
and 100% release in 48 hours. For the nanoparticles with 16% α-tocopherol theoretical loading, 
34% of α-tocopherol was released in one hour and 90% in 48 hours.  
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 CHAPTER 4. CONCLUSION 
The first part of this research was focused on microwave-assisted extraction method 
which proved to be an efficient method for the extraction of rice bran oil and vitamin E 
components from rice bran. Hexane extracted more rice bran oil as compared to isopropanol at 
40ºC. At higher temperature, isopropanol proved to be a better solvent for rice bran oil 
extraction. Hexane extracted large amount of α-tocotrienol at 120ºC, while the increase in 
temperature for isopropanol was more beneficial for the extraction of γ-tocopherol. Also, 
antioxidant activity of isopropanol extracted oil was higher than that of hexane extracted oil; at 
higher temperature isopropanol seemed to extract more antioxidants. No significant differences 
in the oil yield, total vitamin E, and antioxidant activity of rice bran oil was noticed between the 
two extraction methods, conventional solvent and microwave-assisted extractions, at 40ºC.  
Encapsulation of α-tocopherol in the Poly (DL-lactide-co-glycolide) (PLGA) matrix was 
the basis of the second part of this study. Emulsion evaporation method was a suitable technique 
for synthesis of spherical PLGA nanoparticles with entrapped alpha-tocopherol 100 nm in size 
when SDS was used as a surfactant, and less than 250 nm when PVA was used as a surfactant. 
For nanoparticles prepared with SDS, the size of the nanoparticles decreased significantly when 
α-tocopherol was entrapped in the PLGA matrix, while the size of the PVA nanoparticles 
remained unchanged. The polydispersity index after synthesis was lower, under 0.100 for PVA 
nanoparticles and around 0.150 for SDS nanoparticles, and it increased during the purification 
step and during freeze-drying to values as high as 0.250. Zeta potential was negative for all 
nanoparticles prepared with PVA. The entrapment efficiency of α-tocopherol in the polymeric 
matrix was approximately 89% for nanoparticles with 8% α-tocopherol theoretical loading and 
approximately 95% for nanoparticles with 16% α-tocopherol theoretical loading for PVA 
synthesized nanoparticles. The residual PVA associated to the nanoparticles after purification 
was approximately 6% (w/w relative to the amount of nanoparticles) and it was not a function of 
the amount of α-tocopherol entrapped. The release profile of α-tocopherol from PLGA matrix 
was biphasic, showing an initial burst followed by a slower release of the α-tocopherol entrapped 
inside the PLGA matrix. The release for nanoparticles with 8% α-tocopherol theoretical loading 
(86% α-tocopherol released /first hour) was faster than the release for the nanoparticles with 16% 
α-tocopherol theoretical loading (34% α-tocopherol released /first hour). 
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CHAPTER 5. FUTURE WORK 
The main purpose of this thesis was divided into two parts: 1) to extract and quantify 
vitamin E components from the rice bran oil and to test their antioxidant activity and 2) to entrap 
α-tocopherol in the polymeric matrix and to characterize the prepared nanoparticles as well as to 
study the release profile of α-tocopherol from the PLGA matrix. The following future work is 
proposed to further the studied objectives: 
Part I 
• Detailed analysis of antioxidant components of rice bran oil extracted by microwave-
assisted and conventional solvent extractions. 
• Study of the effect of the extraction time on the oil yield and vitamin E components 
by microwave-assisted method.  
• Determination of the extraction efficiency of different solvents in microwave-assisted 
extraction (specifically at high temperature).  
Part II 
• Study the controlled release of α-tocopherol from polymeric nanoparticles in different 
media. If the nanoparticles are used for parenteral administration, PBS is a 
recommended medium to study the release profile in, if the nanoparticles are used in 
a food application, the release profile of α-tocopherol in solutions with different pHs 
and chemical components should be tried. 
• For medical and food applications the use of natural polymers and natural surfactants 
for the preparation of nanoparticles has a crucial importance. 
• Study of alternative purification methods for the removal of the excess surfactant and 
drug, avoiding agglomeration or nanoparticles loss. 
• Study the degradation of α-tocopherol in free form and encapsulated form under 
different environmental conditions. 
• Elucidate the mechanism by which α-tocopherol is reducing the size of nanoparticles 
when it is entrapped in the nanoparticles prepared with SDS. 
• Entrap and release other bioactive components (i.e. ω-3 PUFAs). 
• Test the cellular uptake of PLGA(αT) nanoparticles and study the release profile of α-
tocopherol in cell culture. 
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APPENDIX A. STANDARD CURVES 
A.1. Standard Curve for α-tocopherol 
Standard curve for α-tocopherol by reverse phase high-performance liquid 
chromatography (RP-HPLC), using the column Discovery C18, 25 cm x 4.6 mm, 5 µm (Supelco, 
Sigma-Aldrich Corp., St. Louis, MO, USA), and the detector Waters 474 Scaning Fluorescence 
Detector (Waters Corporation, Milford, MA) set at excitation wavelength 290 nm and emission 
wavelength 320 nm. The mobile phase was acetonitrile: water: acetic acid in a ratio of 95:5:0.01 
at a flow rate of 1.5 ml/min.  Standard curve was prepared with alpha-tocopherol 95% (Sigma 
Chemical Co, St Louis, MO). 
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Figure A.1. Standard curve for alpha-tocopherol 
 
A.2. Standard Curve for PVA 
Standard curve for PVA was prepared using a colorimetric method based on the 
formation of a colored complex between iodine and two adjacent hydroxyl groups of PVA. The 
absorbance of the samples was measured with a UV-Visible Beckman Coulter 
spectrophotometer (Beckman Coulter, Fullerton, CA) at the wavelength 690 nm.  Standard curve 
was prepared with PVA with an average molecular weight of 30,000-70,000 (Sigma Chemical 
Co, St Louis, MO). 
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Figure A.2. Standard curve for PVA 30,000-70,000 Da 
A.3. Standard Curve for Trolox  
Trolox 0.5M was used for the preparation of the standard curve. The decrease in 
absorbance was monitored at 515 nm by using a UV-Visible Beckman Coulter 
spectrophotometer (Beckman Coulter, Fullerton, CA). The readings were done at time zero and 
after 30 min of incubation at room temperature. The inhibition percentage was expressed using 
the following equation:  Inhibition % = (Abst= 0 – Abst= 30 min)/ Abst=0 x 100 ;    
Abst= 0 was the absorbance of DPPH at time zero and Abst= 30 min the absorbance after 30 min of 
incubation. 
y = 0.0405x + 1.593
R2 = 0.9993
0.000
0.500
1.000
1.500
2.000
2.500
3.000
3.500
4.000
0 5 10 15 20 25 30 35
micromol TE/L
In
hi
bi
tio
n 
pe
rc
en
ta
ge
 
Figure A.3. Standard curve for Trolox 
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APPENDIX B. DATA FOR RICE BRAN OIL EXTRACTION 
Table B.1.  Amount of rice bran oil extracted 
Sample 
Empty 
tube Tube +oil(from 2 ml) 
Volume 
(ml) 
g oil/g 
rice bran AVG SD 
I 40 1A ME 8.63 8.75 29.2 0.088   
I 40 2A ME 8.66 8.77 40.5 0.111   
I 40 3A ME 8.67 8.76 53.5 0.120   
I 40 1B ME 8.66 8.8 29.2 0.102   
I 40 2B ME 8.67 8.77 40.5 0.101   
I 40 3B ME 8.72 8.8 53.5 0.107 0.105 0.011 
I 60 1A ME 10.81 10.9 53 0.119   
I 60 2A ME 10.97 11.08 44 0.121   
I 60 3A ME 10.89 10.97 47 0.094   
I 60 1B ME 10.87 10.96 53 0.119   
I 60 2B ME 10.86 10.97 44 0.121   
I 60 3B ME 10.94 11.04 47 0.118 0.115 0.011 
I 80 1A ME 8.69 8.8 60 0.165   
I 80 2A ME 8.67 8.78 50.9 0.140   
I 80 3A ME 10.8 10.91 58.1 0.160   
I 80 1B ME 8.62 8.71 60 0.135   
I 80 2B ME 10.95 11.05 50.9 0.127   
I 80 3B ME 10.92 11.01 58.1 0.131 0.143 0.016 
I 100 1A ME 8.71 8.79 56.5 0.113   
I 100 2A ME 8.64 8.74 53 0.133   
I 100 3A ME 8.61 8.73 62.1 0.186   
I 100 1B ME 8.68 8.79 56.5 0.155   
I 100 2B ME 8.76 8.85 53 0.119   
I 100 3B ME 8.73 8.83 62.1 0.155 0.144 0.027 
I 120 4A ME 8.65 8.79 34.5 0.121   
I 120 5A ME 8.62 8.8 47 0.212   
I 120 6A ME 8.73 8.88 34.1 0.128   
I 120 4B ME 8.78 8.93 34.5 0.129   
I 120 5B ME 8.68 8.84 47 0.188   
I 120 6B ME 8.74 8.89 34.1 0.128 0.151 0.039 
H 40 1A ME 8.68 8.82 43.5 0.152   
H 40 2A ME 8.71 9.47 7 0.133   
H 40 3A ME 8.62 9.31 7.5 0.129   
H 40 1B ME 8.73 8.87 43.5 0.152   
H 40 2B ME 8.67 9.38 7 0.124   
H 40 3B ME 8.68 9.36 7.5 0.128 0.136 0.013 
H 60 1 ME 8.7 8.83 43.5 0.141   
H 60 2 ME 8.72 8.87 38.5 0.144   
H 60 3 ME 8.7 8.83 40.2 0.131   
H 60 1 ME 8.63 8.76 43.5 0.141   
H 60 2 ME 8.75 8.89 38.5 0.135   
H 60 3 ME 8.66 8.8 40.2 0.141 0.139 0.005 
H 80 1 ME 8.62 8.92 17 0.128   
H 80 2 ME 8.58 9.31 7 0.128   
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(table continued)
H 80 3 ME 8.76 9.04 18.9 0.132   
H 80 1 ME 8.71 9.01 17 0.128   
H 80 2 ME 8.59 9.31 7 0.126   
H 80 3 ME 8.56 8.82 18.9 0.123 0.127 0.003 
H 100 1 ME 8.64 8.83 24.1 0.114   
H 100 2 ME 8.62 9.32 7.2 0.126   
H 100 3 ME 8.57 8.84 15.8 0.107   
H 100 1 ME 8.66 8.88 24.1 0.133   
H 100 2 ME 8.61 9.31 7.2 0.126   
H 100 3 ME 8.74 8.98 15.8 0.095 0.117 0.014 
H 120 1 ME 8.65 8.82 29.2 0.124   
H 120 2 ME 8.65 8.98 14.5 0.120   
H 120 3 ME 8.66 8.85 26.7 0.127   
H 120 1 ME 8.72 8.89 29.2 0.124   
H 120 2 ME 8.69 9 14.5 0.112   
H 120 3 ME 8.67 8.85 26.7 0.120 0.121 0.005 
I 40 1A SE 8.64 8.75 52 0.143   
I 40 2A SE 8.74 8.83 46 0.104   
I 40 3A SE 8.64 8.74 45.8 0.115   
I 40 1B SE 8.72 8.81 52 0.117   
I 40 2B SE 8.69 8.79 46 0.115   
I 40 3B SE 8.69 8.8 45.8 0.126 0.120 0.013 
H 40 1A SE 8.61 9.28 8.9 0.149   
H 40 2A SE 8.67 8.97 20.2 0.152   
H 40 3A SE 8.62 8.72 53.8 0.135   
H 40 1B SE 8.68 9.35 8.9 0.149   
H 40 2B SE 8.7 8.98 20.2 0.141   
H 40 3B SE 8.71 8.79 53.8 0.108 0.139 0.017 
ME = Microwave-assisted extraction 
SE = Conventional solvent extraction 
I = Isopropanol 
H = Hexane 
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Table B.2. Vitamin E vitamers and total vitamin E as function of the extraction parameters 
Sample 
Volume 
(ml) 
Area 
aT 
Area 
aT3 
Area 
gT 
Area 
gT3 
µg aT/g 
rb 
µg aT3/g 
rb 
µg gT/g 
rb 
µg gT3/g 
rb 
vitamin E 
µg/g rb 
I 40 1A 29.2 7418962 1434130 1778214 12538069 43.327 8.375 5.192 36.611 93.506 
I 40 2A 40.5 5723041 987815 1336372 9460141 46.357 8.001 5.412 38.314 98.084 
I 40 3A 53.5 3925245 765098 1030765 7279818 42.000 8.187 5.515 38.947 94.648 
I 60 1A 53 4350689 796131 1035969 7425463 46.12 8.44 5.49 39.35 99.40 
I 60 2A 44 4985605 856225 1248186 9122834 43.87 7.53 5.49 40.14 97.04 
I 60 3A 47 4416023 938597 1135010 8570997 41.51 8.82 5.33 40.28 95.95 
I 80 1A 60 3722350 1111677 1068580 7477154 44.67 13.34 6.41 44.86 109.28 
I 80 2A 50.9 6697725 1622204 1235192 8268190 68.18 16.51 6.29 42.09 133.07 
I 80 3A 58.1 5561210 1384099 1083773 7629037 64.62 16.08 6.30 44.32 131.33 
I 100 1B 56.5 5016648 2008043 1201043 7564828 56.69 22.69 6.79 42.74 128.91 
I 100 2A 53 5899716 2053457 1128007 7274557 62.54 21.77 5.98 38.56 128.84 
I 100 3A 62.1 6024991 1912393 1277260 7915675 74.83 23.75 7.93 49.16 155.67 
I 120 1A 52.9 4816656 5361224 1448088 8868232 50.96 56.72 7.66 46.91 162.26 
I 120 2A 43 5683442 6637368 1739888 9600193 48.88 57.08 7.48 41.28 154.72 
I 120 3A 44.2 4925130 5621478 1521527 9046221 43.54 49.69 6.73 39.98 139.94 
H 40 1A 43.5 5070762 1450136 1041857 6310852 44.116 12.616 4.532 27.452 88.716 
H 40 2A 7 12456678 4868420 3720080 17585383 17.439 6.816 2.604 12.310 39.169 
H 40 3A 7.5 12035387 5191047 3480764 16435112 18.053 7.787 2.611 12.326 40.777 
H 60 1A 43.5 4478005 1648333 974042 6753995 38.959 14.340 4.237 29.380 86.916 
H 60 2A 38.5 3588123 1572508 1152128 7429808 27.629 12.108 4.436 28.605 72.777 
H 60 3B 40.2 4726772 1524895 1137970 7449888 38.003 12.260 4.575 29.949 84.787 
H 80 1A 17 7606878 4548897 2197838 14192078 25.863 15.466 3.736 24.127 69.192 
H 80 2A 7 3098353 1785059 737405 5097052 21.688 12.495 2.581 17.840 54.604 
H 80 3A 18.9 8089764 4430009 2114134 12738918 30.579 16.745 3.996 24.077 75.397 
H 100 1B 24.1 7406523 9912236 2034042 10930804 35.699 47.777 4.902 26.343 114.722 
H 100 2A 7.2 3402493 5539277 869913 5175267 24.498 39.883 3.132 18.631 86.143 
H 100 3A 15.8 1409646 3184843 391634 2280145 22.272 50.321 3.094 18.013 93.700 
H 120 1A 29.2 6288136 6198078 1741218 9418341 36.72 180.98 5.08 27.50 250.29 
H 120 2A 14.5 10832973 7757594 2971863 14690384 31.42 112.49 4.31 21.30 169.51 
H 120 3A 26.7 7176490 9655556 1838541 9235920 38.32 257.80 4.91 24.66 325.69 
I 40 1A SE 52 3499813 853032 1148177 7966010 36.398 8.872 5.971 41.423 92.663 
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I 40 2A SE 46 3726624 931935 1317158 9093022 34.285 8.574 6.059 41.828 90.746 
I 40 3A SE 45.8 2929159 871155 1266594 8376166 26.831 7.980 5.801 38.363 78.975 
H 40 1A SE 8.9 12237471 4039393 3588461 17926509 21.783 7.190 3.194 15.955 48.121 
H 40 2A SE 20.2 6794101 2240135 2157801 11009642 27.448 9.050 4.359 22.239 63.097 
H 40 3A SE 53.8 1205204 807286 785670 3872609 12.968 8.686 4.227 20.835 46.716 
SE = Conventional solvent extraction; all the other samples are extracted by microwave-assisted extraction; I = Isopropanol; 
H = Hexane; Area = peak area; aT = alpha-tocopherol; aT3 = alpha-tocotrienol; gT = gamma-tocopherol; gT3 = gamma-tocotrienol; 
rb = rice bran 
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Table B.3. Inhibition percentage as function of the extraction parameters 
Sample volume (µL) g oil/L A t=0 A t=30 min 
Inhibition 
percentage 
I 40 1B 40 0.4 0.5528 0.5141 7.00 
I 40 1B 80 0.8 0.5109 0.4396 13.96 
I 40 1B 120 1.2 0.466 0.3712 20.34 
I 40 2B 40 0.4 0.5669 0.5315 6.24 
I 40 2B 80 0.8 0.5195 0.4622 11.03 
I 40 2B 120 1.2 0.4853 0.41 15.52 
I 40 3B 40 0.4 0.5665 0.5409 4.52 
I 40 3B 80 0.8 0.5289 0.481 9.06 
I 40 3B 120 1.2 0.4936 0.4268 13.53 
I 60 1B 40 0.4 0.5936 0.5586 5.90 
I 60 1B 80 0.8 0.5484 0.487 11.20 
I 60 1B 120 1.2 0.5144 0.4347 15.49 
I 60 2B 40 0.4 0.597 0.5701 4.51 
I 60 2B 80 0.8 0.5625 0.5152 8.41 
I 60 2B 120 1.2 0.5255 0.4518 14.02 
I 60 3B 40 0.4 0.604 0.5816 3.71 
I 60 3B 80 0.8 0.5614 0.5121 8.78 
I 60 3B 120 1.2 0.5293 0.4625 12.62 
I 80 1B 40 0.4 0.5932 0.5607 5.48 
I 80 1B 80 0.8 0.5554 0.494 11.06 
I 80 1B 120 1.2 0.5192 0.4423 14.81 
I 80 2B 40 0.4 0.5943 0.5501 7.44 
I 80 2B 80 0.8 0.5458 0.458 16.09 
I 80 2B 120 1.2 0.5126 0.4079 20.43 
I 80 3B 40 0.4 0.5934 0.5538 6.67 
I 80 3B 80 0.8 0.5537 0.4809 13.15 
I 80 3B 120 1.2 0.5166 0.4225 18.22 
I 100 1B 40 0.4 0.5927 0.5507 7.09 
I 100 1B 80 0.8 0.5546 0.4816 13.16 
I 100 1B 120 1.2 0.5226 0.4282 18.06 
I 100 2B 40 0.4 0.5896 0.542 8.07 
I 100 2B 80 0.8 0.5544 0.4653 16.07 
I 100 2B 120 1.2 0.5116 0.4052 20.80 
I 100 3B 40 0.4 0.5924 0.5515 6.90 
I 100 3B 80 0.8 0.5539 0.4818 13.02 
I 100 3B 120 1.2 0.5225 0.4277 18.14 
I 120 1B 40 0.4 0.5424 0.5034 7.19 
I 120 1B 80 0.8 0.5024 0.4226 15.88 
I 120 1B 120 1.2 0.4622 0.3721 19.49 
I 120 2B 40 0.4 0.5401 0.4869 9.85 
I 120 2B 80 0.8 0.5054 0.4134 18.20 
I 120 2B 120 1.2 0.4649 0.353 24.07 
I 120 3B 40 0.4 0.548 0.507 7.48 
I 120 3B 80 0.8 0.5037 0.4213 16.36 
I 120 3B 120 1.2 0.4692 0.3675 21.68 
H 40 1B 40 0.4 0.5687 0.5407 4.92 
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(table continued) 
H 40 1B 80 0.8 0.536 0.4842 9.66 
H 40 1B 120 1.2 0.5021 0.4287 14.62 
H 40 2B 40 0.4 0.568 0.5383 5.23 
H 40 2B 80 0.8 0.5375 0.4791 10.87 
H 40 2B 120 1.2 0.5054 0.4252 15.87 
H 40 3B 40 0.4 0.5621 0.5389 4.13 
H 40 3B 80 0.8 0.5274 0.476 9.75 
H 40 3B 120 1.2 0.4925 0.4249 13.73 
H 60 1B 40 0.4 0.5972 0.5562 6.87 
H 60 1B 80 0.8 0.5628 0.4918 12.62 
H 60 1B 120 1.2 0.5306 0.4405 16.98 
H 60 2B 40 0.4 0.6022 0.5688 5.55 
H 60 2B 80 0.8 0.5733 0.5102 11.01 
H 60 2B 120 1.2 0.5456 0.4598 15.73 
H 60 3A 40 0.4 0.5994 0.5649 5.76 
H 60 3A 80 0.8 0.5681 0.5048 11.14 
H 60 3A 120 1.2 0.5409 0.4544 15.99 
H 80 1B 40 0.4 0.6062 0.5842 3.63 
H 80 1B 80 0.8 0.588 0.546 7.14 
H 80 1B 120 1.2 0.5576 0.4963 10.99 
H 80 2B 40 0.4 0.5975 0.5603 6.23 
H 80 2B 80 0.8 0.5639 0.5036 10.69 
H 80 2B 120 1.2 0.5274 0.4297 18.52 
H 80 3B 40 0.4 0.6006 0.5695 5.18 
H 80 3B 80 0.8 0.5686 0.5082 10.62 
H 80 3B 120 1.2 0.5336 0.4501 15.65 
H 100 1A 40 0.4 0.5948 0.559 6.02 
H 100 1A 80 0.8 0.5575 0.4925 11.66 
H 100 1A 120 1.2 0.5244 0.4346 17.12 
H 100 2B 40 0.4 0.5961 0.5594 6.16 
H 100 2B 80 0.8 0.5603 0.4935 11.92 
H 100 2B 120 1.2 0.5319 0.4396 17.35 
H 100 3B 40 0.4 0.5931 0.5538 6.63 
H 100 3B 80 0.8 0.5558 0.4862 12.52 
H 100 3B 120 1.2 0.5224 0.4266 18.34 
H 120 4B 40 0.4 0.5559 0.5166 7.07 
H 120 4B 80 0.8 0.5166 0.4503 12.83 
H 120 4B 120 1.2 0.4806 0.3918 18.48 
H 120 5B 40 0.4 0.5577 0.518 7.12 
H 120 5B 80 0.8 0.522 0.4479 14.20 
H 120 5B 120 1.2 0.4829 0.3933 18.55 
H 120 6B 40 0.4 0.5556 0.5157 7.18 
H 120 6B 80 0.8 0.5151 0.4438 13.84 
H 120 6B 120 1.2 0.4828 0.3877 19.70 
I 40 1B SE 40 0.4 0.5565 0.5324 4.33 
I 40 1B SE 80 0.8 0.5127 0.4689 8.54 
I 40 1B SE 120 1.2 0.4714 0.4097 13.09 
I 40 2B SE 40 0.4 0.5536 0.5277 4.68 
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(table continued) 
I 40 2B SE 80 0.8 0.5081 0.4607 9.33 
I 40 2B SE 120 1.2 0.4664 0.4025 13.70 
I 40 3B SE 40 0.4 0.5546 0.5294 4.54 
I 40 3B SE 80 0.8 0.5116 0.4648 9.15 
I 40 3B SE 120 1.2 0.4665 0.3998 14.30 
H 40 1B SE 40 0.4 0.5637 0.539 4.38 
H 40 1B SE 80 0.8 0.5263 0.4762 9.52 
H 40 1B SE 120 1.2 0.494 0.4254 13.89 
H 40 2B SE 40 0.4 0.5647 0.5269 6.69 
H 40 2B SE 80 0.8 0.5319 0.4687 11.88 
H 40 2B SE 120 1.2 0.5031 0.4172 17.07 
H 40 3B SE 40 0.4 0.5666 0.5339 5.77 
H 40 3B SE 80 0.8 0.5348 0.4708 11.97 
H 40 3B SE 120 1.2 0.512 0.4271 16.58 
SE = Conventional solvent extraction; all the other samples are extracted by microwave-assisted 
extraction; I = Isopropanol; H = Hexane.  
 
Table B.4. Degradation of α-tocopherol by microwave-assisted method 
Sample Area aT µg/L aT g/L AVG SD 
I1 TE only 6834129 136682.6 0.137   
I2 TE only 7011893 140237.9 0.140   
I3 TE 5 6765515 135310.3 0.135 0.137 0.003 
I 40 1A 7546544 150930.9 0.151   
I 40 2A 7177580 143551.6 0.144   
I 40 3A 6609213 132184.3 0.132 0.142 0.009 
I 60 1A 6329453 126589.1 0.127   
I 60 2A 5929483 118589.7 0.119   
I 60 3A 6974842 139496.8 0.139 0.128 0.011 
I 80 1A 7167328 143346.6 0.143   
I 80 2A 7360587 147211.7 0.147   
I 80 3A 6996088 139921.8 0.140 0.143 0.004 
I 100 1A 6907396 138147.9 0.138   
I 100 2A 6559570 131191.4 0.131   
I 100 3A 7047293 140945.9 0.141 0.137 0.005 
I 120 1A 7014736 140294.7 0.140   
I 120 2A 7250917 145018.3 0.145   
I 120 3A 7139137 142782.7 0.143 0.143 0.002 
H1 t=0  5 5462207 109244.1 0.109   
H2 t=0  5 5665997 113319.9 0.113   
H3 t=0  5 5654728 113094.6 0.113 0.112 0.002 
H1 TE 5 5650688 113013.8 0.113   
H2 TE 5 5670571 113411.4 0.113   
H3 TE 5 5601455 112029.1 0.112 0.113 0.001 
H 40 1A 5883153 117663.1 0.118   
H 40 2A 6344210 126884.2 0.127   
H 40 3A 5992039 119840.8 0.120 0.121 0.005 
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H 60 1A 6240268 124805.4 0.125   
H 60 2A 5898742 117974.8 0.118   
H 60 3A 6161420 123228.4 0.123 0.122 0.004 
H 80 1A 6213527 124270.5 0.124   
H 80 2A 6141728 122834.6 0.123   
H 80 3A 4950429 99008.58 0.099 0.115 0.014 
H 100 1A 5752133 115042.7 0.115   
H 100 2A 6393477 127869.5 0.128   
H 100 3A 6825664 136513.3 0.137 0.126 0.011 
H 120 1A 6219045 124380.9 0.124   
H 120 2A 6031576 120631.5 0.121   
H 120 3A 5863611 117272.2 0.117 0.121 0.004 
I = Isopropanol; H = Hexane; TE = evaporation temperature. 
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APPENDIX C. DATA FOR CHARACTERIZATION AND REALEASE OF ALPHA-TOCOPHEROL 
ENTRAPPED IN THE PLGA MATRIX 
Table C.1. Size, PDI, and zeta potential for nanoparticles as a function of alpha-tocopherol theoretical loading  
and processing parameters after synthesis  
Record Type Sample Name Measurement Date and Time T (°C)
Z-Ave 
(d.nm) PDI 
ZP 
(mV) 
4 Size E1 repeated bp Friday, October 20, 2006 3:30:43 PM 25 219 0.059 n/a 
5 Size E1 repeated bp Friday, October 20, 2006 3:33:15 PM 25 219 0.103 n/a 
6 Size E1 repeated bp Friday, October 20, 2006 3:35:46 PM 25 215 0.084 n/a 
22 Size E2 repeated bp Saturday, October 21, 2006 6:54:59 PM 25 221 0.128 n/a 
23 Size E2 repeated bp Saturday, October 21, 2006 6:57:30 PM 25 219 0.06 n/a 
24 Size E2 repeated bp Saturday, October 21, 2006 7:00:01 PM 25 218 0.095 n/a 
16 Size E3bp Saturday, October 21, 2006 3:01:08 PM 25 213 0.07 n/a 
17 Size E3bp Saturday, October 21, 2006 3:03:39 PM 25 212 0.076 n/a 
18 Size E3bp Saturday, October 21, 2006 3:06:11 PM 25 210 0.069 n/a 
25 Size S1 double repeated,aT8%bp Wednesday, October 18, 2006 11:07:22 AM 25 200 0.078 n/a 
26 Size S1 double repeated,aT8%bp Wednesday, October 18, 2006 11:09:54 AM 25 201 0.074 n/a 
27 Size S1 double repeated,aT8%bp Wednesday, October 18, 2006 11:12:25 AM 25 200 0.103 n/a 
7 Size S2aT8%bp Monday, October 16, 2006 3:54:11 PM 25 224 0.105 n/a 
8 Size S2aT8%bp Monday, October 16, 2006 3:56:42 PM 25 226 0.094 n/a 
9 Size S2aT8%bp Monday, October 16, 2006 3:59:14 PM 25 222 0.105 n/a 
19 Size S3,aT8%bp Tuesday, October 17, 2006 6:33:30 PM 25 228 0.083 n/a 
20 Size S3,aT8%bp Tuesday, October 17, 2006 6:36:02 PM 25 227 0.105 n/a 
21 Size S3,aT8%bp Tuesday, October 17, 2006 6:38:33 PM 25 227 0.092 n/a 
31 Size D1aT16%bp Wednesday, October 18, 2006 1:09:44 PM 25 216 0.102 n/a 
32 Size D1aT16%bp Wednesday, October 18, 2006 1:12:17 PM 25 212 0.086 n/a 
33 Size D1aT16%bp Wednesday, October 18, 2006 1:14:48 PM 25 215 0.051 n/a 
55 Size D2 double repeated aT16%bp Friday, October 20, 2006 1:30:38 PM 25 212 0.069 n/a 
56 Size D2 double repeated aT16%bp Friday, October 20, 2006 1:33:09 PM 25 211 0.092 n/a 
57 Size D2 double repeated aT16%bp Friday, October 20, 2006 1:35:39 PM 25 208 0.025 n/a 
43 Size D3aT16%bp Wednesday, October 18, 2006 5:25:09 PM 25 197 0.055 n/a 
44 Size D3aT16%bp Wednesday, October 18, 2006 5:27:40 PM 25 193 0.036 n/a 
45 Size D3aT16%bp Wednesday, October 18, 2006 5:30:10 PM 25 193 0.033 n/a 
7 Size E1 repeated ap Friday, October 20, 2006 4:39:43 PM 25 229 0.15 n/a 
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8 Size E1 repeated ap Friday, October 20, 2006 4:42:14 PM 25 229 0.083 n/a 
9 Size E1 repeated ap Friday, October 20, 2006 4:44:46 PM 25 226 0.114 n/a 
25 Size E2 repeated ap Saturday, October 21, 2006 7:04:03 PM 25 243 0.191 n/a 
26 Size E2 repeated ap Saturday, October 21, 2006 7:06:34 PM 25 251 0.277 n/a 
27 Size E2 repeated ap Saturday, October 21, 2006 7:09:06 PM 25 238 0.173 n/a 
19 Size E3ap Saturday, October 21, 2006 4:05:56 PM 25 229 0.177 n/a 
20 Size E3ap Saturday, October 21, 2006 4:08:28 PM 25 222 0.121 n/a 
21 Size E3ap Saturday, October 21, 2006 4:10:59 PM 25 219 0.135 n/a 
28 Size S1 double repeated,aT8%ap Wednesday, October 18, 2006 12:59:38 PM 25 218 0.081 n/a 
29 Size S1 double repeated,aT8%ap Wednesday, October 18, 2006 1:02:09 PM 25 211 0.121 n/a 
30 Size S1 double repeated,aT8%ap Wednesday, October 18, 2006 1:04:40 PM 25 215 0.086 n/a 
10 Size S2aT8%ap Monday, October 16, 2006 6:38:29 PM 25 227 0.121 n/a 
11 Size S2aT8%ap Monday, October 16, 2006 6:41:00 PM 25 226 0.178 n/a 
12 Size S2aT8%ap Monday, October 16, 2006 6:43:32 PM 25 227 0.106 n/a 
22 Size S3,aT8%ap Tuesday, October 17, 2006 7:56:15 PM 25 240 0.182 n/a 
23 Size S3,aT8%ap Tuesday, October 17, 2006 7:58:45 PM 25 235 0.197 n/a 
24 Size S3,aT8%ap Tuesday, October 17, 2006 8:01:16 PM 25 233 0.099 n/a 
34 Size D1aT16%ap Wednesday, October 18, 2006 3:00:26 PM 25 231 0.111 n/a 
35 Size D1aT16%ap Wednesday, October 18, 2006 3:03:00 PM 25 230 0.168 n/a 
36 Size D1aT16%ap Wednesday, October 18, 2006 3:05:31 PM 25 227 0.117 n/a 
58 Size D2 double repeated aT16%ap Friday, October 20, 2006 3:20:37 PM 25 240 0.199 n/a 
59 Size D2 double repeated aT16%ap Friday, October 20, 2006 3:23:08 PM 25 235 0.146 n/a 
60 Size D2 double repeated aT16%ap Friday, October 20, 2006 3:25:39 PM 25 233 0.105 n/a 
46 Size D3aT16%ap Wednesday, October 18, 2006 6:28:59 PM 25 215 0.269 n/a 
47 Size D3aT16%ap Wednesday, October 18, 2006 6:31:31 PM 25 200 0.167 n/a 
48 Size D3aT16%ap Wednesday, October 18, 2006 6:34:02 PM 25 201 0.074 n/a 
40 Size/ZP E1 after fd Tuesday, October 24, 2006 5:49:19 PM 25 231 0.077 -26.7 
41 Size/ZP E1 after fd Tuesday, October 24, 2006 5:51:50 PM 25 226 0.167 -27.2 
42 Size/ZP E1 after fd Tuesday, October 24, 2006 5:54:21 PM 25 223 0.113 -27.1 
43 Size/ZP E2 after  fd Tuesday, October 24, 2006 5:58:41 PM 25 247 0.146 -30.5 
44 Size/ZP E2 after  fd Tuesday, October 24, 2006 6:01:11 PM 25 239 0.128 -31.5 
45 Size/ZP E2 after  fd Tuesday, October 24, 2006 6:03:41 PM 25 242 0.151 -30.4 
46 Size/ZP E3 after  fd Tuesday, October 24, 2006 6:10:10 PM 25 230 0.127 -29.6 
47 Size/ZP E3 after  fd Tuesday, October 24, 2006 6:12:41 PM 25 228 0.146 -27.5 
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48 Size/ZP E3 after  fd Tuesday, October 24, 2006 6:15:12 PM 25 229 0.13 -27.5 
1 Size/ZP S1 after fd Monday, October 23, 2006 8:00:42 PM 25 296 0.293 -14.9 
2 Size/ZP S1 after fd Monday, October 23, 2006 8:03:13 PM 25 269 0.236 -16.7 
3 Size/ZP S1 after fd Monday, October 23, 2006 8:05:44 PM 25 262 0.215 -16.4 
4 Size/ZP S2 after fd Monday, October 23, 2006 8:09:13 PM 25 312 0.257 -14 
5 Size/ZP S2 after fd Monday, October 23, 2006 8:11:45 PM 25 310 0.26 -14 
6 Size/ZP S2 after fd Monday, October 23, 2006 8:14:16 PM 25 299 0.259 -13.5 
7 Size/ZP S3 after fd Monday, October 23, 2006 8:24:43 PM 25 279 0.224 -10.8 
8 Size/ZP S3 after fd Monday, October 23, 2006 8:27:13 PM 25 264 0.189 -10.2 
9 Size/ZP S3 after fd Monday, October 23, 2006 8:29:46 PM 25 265 0.221 -11.5 
10 Size/ZP D1 after fd Monday, October 23, 2006 8:33:27 PM 25 248 0.173 -9.58 
11 Size/ZP D1 after fd Monday, October 23, 2006 8:36:21 PM 25 246 0.136 -10.6 
12 Size/ZP D1 after fd Monday, October 23, 2006 8:38:52 PM 25 242 0.146 -10.7 
13 Size/ZP D2 after fd Monday, October 23, 2006 8:42:38 PM 25 259 0.215 -19.4 
14 Size/ZP D2 after fd Monday, October 23, 2006 8:45:09 PM 25 250 0.158 -19.6 
15 Size/ZP D2 after fd Monday, October 23, 2006 8:47:39 PM 25 251 0.202 -19 
16 Size/ZP D3 after fd Monday, October 23, 2006 8:50:45 PM 25 220 0.109 -8.34 
17 Size/ZP D3 after fd Monday, October 23, 2006 8:53:16 PM 25 217 0.141 -8.51 
18 Size/ZP D3 after fd Monday, October 23, 2006 8:55:47 PM 25 216 0.112 -8.19 
E = unloaded nanoparticles; S = nanoparticles with 8% alpha-tocopherol theoretical loading; D = nanoparticles with 16% alpha-
tocopherol theoretical loading; bp = before purification; ap = after purification; fd = freeze-drying; ZP = zeta potential; aT = alpha-
tocopherol. 
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Table C.2. Entrapment efficiency of alpha-tocopherol entrapped in the polymeric matrix 
Sample Area 
Amount 
sample (mg) µg aT/ 25 µL 
µg aT/ 1 mg 
sample mg aT/sample EE% AVG 
 
SD 
S1 8% 25 µL R1 8258444 134.9 0.826 33.034 4.456 111.406   
S1 8% 25 µL R2 7600643 134.9 0.760 30.403 4.101 102.533   
S1 8% 25 µL R3 7290680 134.9 0.729 29.163 3.934 98.351   
S2 8% 25 µL R1 6775130 127.6 0.678 27.101 3.458 86.451   
S2 8% 25 µL R2 6669332 127.6 0.667 26.677 3.404 85.101   
S2 8% 25 µL R3 6599460 127.6 0.660 26.398 3.368 84.209   
S3 8% 25 µL R1 5827790 136.9 0.583 23.311 3.191 79.782   
S3 8% 25 µL R2 5818163 136.9 0.582 23.273 3.186 79.651   
S3 8% 25 µL R3 5787447 136.9 0.579 23.150 3.169 79.230 89.63 11.63 
D1 16% 25 µL R1 13618551 135.6 1.362 54.474 7.387 92.334   
D1 16% 25 µL R2 13640790 135.6 1.364 54.563 7.399 92.485   
D1 16% 25 µL R3 13640648 135.6 1.364 54.563 7.399 92.484   
D2 16% 25 µL R1 15041241 135.5 1.504 60.165 8.152 101.904   
D2 16% 25 µL R2 14427252 135.5 1.443 57.709 7.820 97.745   
D2 16% 25 µL R3 14055900 135.5 1.406 56.224 7.618 95.229   
D3 16% 25 µL R1 14395105 132.9 1.440 57.580 7.652 95.655   
D3 16% 25 µL R2 14549037 132.9 1.455 58.196 7.734 96.678   
D3 16% 25 µL R3 14416846 132.9 1.442 57.667 7.664 95.800 95.59 3.08 
S = nanoparticles with 8% alpha-tocopherol theoretical loading; D = nanoparticles with 16% alpha-tocopherol theoretical loading; 
R 1,2,3 = HPLC injection 1,2,3 (25 µL injected volume).  
Table C.3. Residual PVA associated with nanoparticles as a function of alpha-tocopherol theoretical loading 
Sample Absorbance PVA mg/ml PVA mg/2 ml PVA % (w/w) relative to n.p. AVG SD 
E1 0% 0.3313 0.080 0.160 5.34   
E2 0% 0.2831 0.069 0.139 4.62   
E3 0% 0.329 0.080 0.159 5.31 5.09 0.41 
S1 8% 0.428 0.102 0.204 6.80   
S2 8% 0.3785 0.091 0.182 6.05   
S3 8% 0.4784 0.113 0.227 7.56 6.80 0.75 
D1 16% 0.3951 0.095 0.189 6.30   
D2 16% 0.3914 0.094 0.187 6.25   
D3 16% 0.5689 0.134 0.268 8.92 7.16 1.53 
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Table C.4. Alpha-tocopherol released from PLGA nanoparticles as a function of time 
Sample Area 
µg aT/50 
µL 
µg aT/ 1 
mL 
µg aT/ 
10 mg 
np 
% alpha-
tocopherol 
released AVG SD 
S1 t=0 264782 0.0264782 0.529564 5.29564 0.00   
S2 t=0 384441 0.0384441 0.768882 7.68882 0.00 0.00 0.00 
S1 t=1 h 37494 0.0037494 0.074988 0.74988 85.84   
S2 t=1 h 48044 0.0048044 0.096088 0.96088 87.50 86.67 1.18 
S1 t=3 h 17636 0.0017636 0.035272 0.35272 93.34   
S2 t=3 h 11492 0.0011492 0.022984 0.22984 97.01 95.18 2.60 
S1 t=5 h 32830 0.003283 0.06566 0.6566 87.60   
S2 t=5 h 7829 0.0007829 0.015658 0.15658 97.96 92.78 7.33 
S1 t=7 h 21329 0.0021329 0.042658 0.42658 91.94   
S2 t=7 h 4586 0.0004586 0.009172 0.09172 98.81 95.38 4.85 
S1 t=24 h 13463 0.0013463 0.026926 0.26926 94.92   
S2 t=24 h 2419 0.0002419 0.004838 0.04838 99.37 97.14 3.15 
S1 t=48 h 0 0 0 0 100   
S2 t=48 h 0 0 0 0 100 100.00 0.00 
D1 t=0 3234642 0.3234642 6.469284 64.69284 0.00   
D2 t=0 2405665 0.2405665 4.81133 48.1133 0.00 0.00 0.00 
D1 t=1 h 1996070 0.199607 3.99214 39.9214 38.29   
D2 T=1 h 1657070 0.165707 3.31414 33.1414 31.12 34.70 5.07 
D1 t=3 h 1479813 0.1479813 2.959626 29.59626 54.25   
D2 t=3 h 1163229 0.1163229 2.326458 23.26458 51.65 52.95 1.84 
D1 t=5 h 1215957 0.1215957 2.431914 24.31914 62.41   
D2 t=5 h 915312 0.0915312 1.830624 18.30624 61.95 62.18 0.32 
D1 t=7 h 1043636 0.1043636 2.087272 20.87272 67.74   
D2 t=7 h 778981 0.0778981 1.557962 15.57962 67.62 67.68 0.08 
D1 t=24 h 517770 0.051777 1.03554 10.3554 83.99   
D2 t=24 h 443864 0.0443864 0.887728 8.87728 81.55 82.77 1.73 
D1 t=48 h 223440 0.022344 0.44688 4.4688 93.09   
D2 t=48 h 281253 0.0281253 0.562506 5.62506 88.31 90.70 3.38 
S = nanoparticles with 8% alpha-tocopherol theoretical loading; D = nanoparticles with 16% 
alpha-tocopherol theoretical loading  
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